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Home Field ADVANTAGE
AS VICE PRESIDENT AND DEAN, JEFFREY S. AKMAN, M.D. ’81, G.M.E. ’85
LEVERAGES HIS LONG-STANDING CONNECTION TO GW

A note from Ross Hall

Facing Our Future

T

his time of year, with graduation ceremonies
taking place and excitement in the air, one
naturally focuses on the future. Whether we are
graduating from one of GW’s health sciences or
Ph.D. programs, completing medical school or
residency, preparing for the incoming residents, or
even turning in an annual report as a faculty member — we
all have our eyes on what lies ahead. For many of us, it is a
time to celebrate our successes, seize new opportunities, and
create the future.
As I reflect on my own graduation from GW’s School
of Medicine and Health Sciences (SMHS) in May 1981,
I remember deans Bowles and Keimowitz outlining the
amazing opportunities that were ahead of us at the time.
Their optimistic words of wisdom sent us off into a world
that I now realize is much more unpredictable than I
imagined that afternoon. In the following years, health
care would experience unimaginable challenges, such as the
HIV/AIDS epidemic, as well as major medical advances,
including robots in the operating room. We would begin to
realize the promise of genomics and personalized medicine.

Each year, our commencement speakers impress
upon our graduates the importance of their roles as health
professionals in society. They reflect upon the incredible
accomplishments each graduate has already attained. They
talk about the future, the path to success, and the exciting
opportunities that await graduates. And as always, our graduates will transition into a world with new diseases ahead,
technologies that have yet to be created, and undiscovered
treatments that will transform the field.
Yet, this is the most exciting time to be in medicine,
health care, and biomedical science. There will be challenges,
of course, in the form of sequestration and cuts to NIH
funding, along with new models of care and reimbursement
under the Affordable Care Act — challenges unforeseen
to classes of the past. However, with full confidence, I can
assure our graduates that they not only will be prepared for
the ever-changing health care landscape and scientific landscape, but they also have the knowledge, skills, and creativity
to embrace these challenges and create the future of medicine and health care.
In addition to preparing students for the terrain ahead,
GW School of Medicine and Health Sciences, as an institution, is also creating its own future. As you may know, in
January, I was appointed as the vice president for health
affairs and dean of the School of Medicine and Health
Sciences. In this new role, I have traveled extensively,
discussing potential opportunities, seeking new partnerships, and looking for creative ways for alumni and friends
of the school to get involved with and support SMHS. I have
benefited enormously from meeting our alumni eager to share
stories about their GW experiences and to offer input on
how to navigate our institution through the next decade and
beyond. With our remarkable 188-year history as a foundation, and with a dynamic constituency of students, residents,
faculty, and alumni as supporters, I am profoundly grateful
for the opportunity to lead the GW SMHS during this most
exciting time to its next level of greatness.
Sincerely,

JEFFREY S. AKMAN, M.D. ’81, G.M.E. ’85
VICE PRESIDENT FOR HEALTH AFFAIRS
AND DEAN, SCHOOL OF MEDICINE
AND HEALTH SCIENCES

The George Washington University
W. RUSSELL RAMSEY, B.B.A. ’81
Chair, Board of Trustees
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MAKING THE ROUNDS
March Match Up
In the minutes leading up to Match Day, Alex Sims, a fourthyear medical student at the George Washington University
(GW) School of Medicine and Health Sciences (SMHS), was
a mixed bag of emotions — nervous about possibly matching
with a residency program far from her family, sad to leave the
place she had called home for the past four years, and, most
importantly, excited for her future.
Held on March 15 this year, Match Day is the transition
point between medical school and residency.
“Match Day is a phenomenal day in the life of a medical
student,” said Jeffrey S. Akman, M.D. ’81, G.M.E. ’85,
vice president for health affairs and dean of SMHS. “Our
students match with some of the leading medical institutions in the country.”
As the noon deadline, when medical students across
the country get the news on their matches, neared, SMHS
students filled Ross Hall to celebrate.
Cheers, tears, hugs, and laughter followed as SMHS
students received and opened their envelopes from the
National Resident Matching Program, a nonprofit corporation established to provide a uniform date of appointment to
positions in graduate medical education in the United States.
Fighting back tears, Sims opened her letter. “I feel so
lucky to get my first choice,” said Sims, who matched in pediatrics–primary care at Children’s National Medical Center in
Washington, D.C.
Across the room, Siobhan Hartigan and Christal Achille,
both fourth-year medical students at SMHS, couldn’t stop
smiling after being matched. Best friends since middle
school, Hartigan and Achille have always been there for
each other. “It means a lot to me to have someone I know
from home be by my side as I go through this process,” said
Achille. The girls will be apart for the first time in years as
Achille, a Long Island, N.Y., native, is going back home to
Stony Brook University Medical Center, where she matched
in pediatrics. Hartigan matched in urology at the University
of Pennsylvania.
Children’s National Medical Center in Washington,
D.C.; Johns Hopkins Hospital in Baltimore, Md.; and
Vanderbilt University Medical Center in Nashville, Tenn.,
are just some of the leading institutions that SMHS students
matched with this year. Thirteen students will continue their
training here at GW .

>> On the web
Scan this QR code with any mobile device to view
a complete list of this year’s SMHS matches.
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Christopher D’Avella, M.D. ’13, shares his news that
he matched in internal medicine at the University of
Pittsburgh Medical Center, with classmates (from left)
Sagine Berry-Tony and Yevgeniya “Gena” Gora.

Daniel O’Neill, M.D. ’13, opens his match letter as his
father prepares to capture the moment in a photo.

Alexandra Sims, M.D. ’13, is moved to tears by the news
she matched with her top choice, Children’s National
Medical Center, as classmate Carrie Pinchbeck
and friend Brandon Roberts look on.

Third-year Ph.D. student Kristin Ceniccola
presents her research poster at this year’s Research Day.

Medicine and Health Research Day
Students and residents presented more than 300 posters
at Medicine and Health Research Day. The scope of
posters ranged from basic science research to translational
science projects.
For many presenters, the day is the culmination of years
of hard work, said Vincent A. Chiappinelli, Ph.D., interim
associate vice president for Health Affairs and associate dean
of the GW School of Medicine and Health Sciences (SMHS).
“Medicine and Health Research Day is a celebration for
the school to highlight the research efforts of our faculty,
graduate students, residents, and medical students,” said
Jeffrey Akman, M.D. ’81, G.M.E. ’85, vice president for
health affairs and dean of SMHS.
The theme for 2013 was HIV/AIDS. “We decided to
focus on HIV/AIDS because our faculty has been at the
forefront of HIV/AIDS research for decades,” added Akman.
Gary Simon, director of the division of infectious
diseases, vice chair of the Department of Medicine, Walter
G. Ross Professor of Medicine and of Microbiology and
Tropical Medicine, and professor of biochemistry and molecular biology at SMHS, delivered the first keynote address.

Simon shared his personal journey with HIV/AIDS —
from researching its causes and prevalence in the District to
experimenting with different treatment drugs to uncovering
new preventive measures.
Alan Greenberg, M.D. ’82, professor and chair of the
Department of Epidemiology and Biostatistics at GW’s
School of Public Health and Health Services, and director of
the District of Columbia Developmental Center for AIDS
Research (D.C. D-CFAR), delivered the second keynote
address.
Greenberg gave an overview of HIV/AIDS epidemiology
and prevention and addressed the HIV/AIDS work that is
currently being done in Washington, D.C.

>> On the web
Scan this QR code with any mobile device to
view a complete list of the 2013 Research Day
award winners.
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Renowned HIV/AIDS Researcher
Joins GW
The George Washington University (GW) School of
Medicine and Health Sciences (SMHS) is pleased to
announce that HIV/AIDS researcher Douglas F. Nixon,
M.D., Ph.D., will be joining the faculty on Oct. 1, 2013, as
the Ross Professor of Basic Science Research and chair of
the Department of Microbiology, Immunology, and Tropical
Medicine (MITM).
Nixon has pursued immunovirology research for more
than 25 years; his studies have included clinical research,
human immunology, basic virology, and molecular biology.
Over the past two decades, he has focused on the cellular
immune response to retrovirus infections and has published
extensively on this topic. Nixon gained recognition for
publishing the first identification of an HIV-specific cytotoxic T cell CTL epitope, in the journal Nature.
“Dr. Nixon is going to be a great addition and an
inspiring leader for the department’s faculty, students, and
staff. His expansive research portfolio and vast expertise
will enable the department to maintain its highly regarded
reputation and expand its signature programs,” said Jeffrey S.
Akman, M.D. ’81, G.M.E. ’85, vice president for health affairs
and dean of SMHS.
Nixon’s research is funded through grants from the
NIH, including an NIH Merit Award, AmfAR, and the
Gates Foundation. He is the chair of the NIH AIDS
Vaccine Research Subcommittee, is a scientist of the
Elizabeth Glaser Pediatric AIDS Foundation, delivered the
Distinguished Science Lecture in 2009 at the NIH Rocky
Mountain Laboratories, and is a member of several leading
professional organizations.
He was named as one of the 2012 POZ 100, which is an
elite group of scientists, researchers, advocates, politicians,
and celebrities who are recognized by POZ Magazine for their
significant contributions to speeding up the end of AIDS.
“Infectious diseases are a global problem, and also
manifest at a local level. In Washington, D.C., the prevalence
of HIV infection is one of the highest in the nation,” said
Nixon. “By studying infectious diseases at a local and global
level, research at MITM, in very close collaboration with
colleagues throughout GW, can contribute to new discoveries
for biomarkers, diagnostics, and vaccines, and novel treatments for these diseases.”
4 GWMEDICINEHEALTH.COM • S P R I N G 2 0 1 3

GW Heart and Vascular Institute
Forges Public Health Partnership
The George Washington University (GW) Heart & Vascular
Institute and The Wireless Foundation, in partnership with
the D.C. Fire and Emergency Medical Services, announced
an innovative new public health initiative. The collaboration
is designed to improve cardiac care in the nation’s capital.
Through this initiative, D.C.-area ambulances have been
equipped with technology that enables rapid, wireless transmissions of EKGs to be sent to both the on-call physician’s
wireless device and tertiary care hospitals.
“This technology will allow the medical team to make
decisions early, in many cases before the patient even
arrives at the hospital, and should significantly improve
the outcomes of patients,” said Jonathan Reiner, M.D.,
professor of medicine at GW’s School of Medicine and
Health Sciences.

Advocating Her Way to Wellness
and a Better Education
Ask medical students what is most important to them and
you get similar responses — support for their education
and overall well-being. That’s certainly the case for Amy
Waldner, a third-year medical student at GW’s School of
Medicine and Health Sciences (SMHS), who will use her new
leadership role to advocate for her fellow medical students.
As of January, Waldner is the GW student representative to

MAKING THE ROUNDS
the Organization of Student Representatives (OSR), and she
was elected as a national delegate to the OSR Administrative
Board. Founded to represent medical students nationwide, the OSR ensures that students actively participate in
directing their education, while working with the Association
of American Medical Colleges (AAMC) to improve the
nation’s health. Waldner will represent students in the
AAMC by providing feedback on the programs and services
that are sponsored by the organization, then disseminating
that information to her fellow students.
The key to success in Waldner’s new role is keeping
current. “I have to stay up-to-date on everything from new
recommendations for applications to residency, to away rotations, to national residency matching programs, to MCAT
changes,” she said. Most importantly, her role is to stand up
for students, said Waldner.
In her new position, Waldner will work closely with
Scott Schroth, M.D., M.P.H., associate dean for administration at SMHS and chair of the Group on Student Affairs
(GSA) Steering Committee for the AAMC.
Student wellness is a major initiative that falls under the
student affairs umbrella, said Schroth and Waldner. “We are
trying to focus not just on emotional and mental health wellness, but also physical and spiritual wellness,” said Schroth.
Waldner echoes Schroth’s desire to ensure that students’
needs beyond academics are met. “It’s my job to make sure
that students know what resources are available in terms of
wellness,” said Waldner.
Waldner is also learning how to advocate for herself and,
most importantly, her future patients. “In a sense, patients
are voiceless. You need to know how the legislative system
operates, as well as the different points of entry for advocating on behalf of your patients.”

GW PA Students Support Clinical
Officer Training Program in Rwanda
The GW Physician Assistant (PA) program and the
Rwandan Embassy have joined forces to bring lab coats,
training supplies, and textbooks to Rwandan health
professional students.
Lisa Alexander, Ed.D., M.P.H., P.A. ’79, director of
GW’s PA program, served as a Fulbright senior specialist
to the Ministry of Education in Rwanda in 2009–10 to
determine how best to meet the existing health workforce
shortages, especially in rural primary care. After completing
a feasibility study, she collaborated with faculty at the Kigali
Health Institute to develop the curriculum. Even with these
resources, and despite several attempts to secure additional

government or international monies, the funding for the
program was severely limited.
The Clinical Officer program, however, has persevered
through these challenges and has been able to accept its
first class of students in 2012. It is in the process of training
its first cohort of 150 students to function as the country’s
newest health professionals.

No Stone Unturned
In the United States, one in 10 men and one in 14 women has
had a kidney stone. Jeremy Brown, M.D., associate professor
of emergency medicine at the GW School of Medicine and
Health Sciences, has received a grant to explore new ways to
treat kidney stones.
Brown received a four-year, $4.2 million cooperativeagreement research project grant from the National
Institutes of Health and the National Institute of Diabetes
and Digestive and Kidney Diseases. His research project
will enroll patients with kidney stones in three emergency
departments (EDs), including the ED at GW Hospital,
and randomize them to either an active medication called
Tamsulosin or a placebo.
Brown believes treatment with Tamsulosin may
help patients pass their kidney stones faster and with
fewer complications.

Headlining Hedgehogs
Many researchers believe that the Hedgehog (Hh) signaling
pathway, which transmits information to embryonic cells for
proper development and is important for regeneration, may
actually regulate cell-to-cell adhesion and segregation — but
there isn’t any evidence it’s true. Xiaoyan Zheng, Ph.D.,
assistant professor of anatomy and regenerative biology at
GW’s School of Medicine and Health Sciences, is working
to change that. With a $747,000 grant from the Eunice
Kennedy Shriver National Institute of Child Health and
Human Development at the National Institutes of Health,
Zheng will focus on identifying the mechanism involved in
this process.
“This is a very fundamental question, but a very
important question, especially in the process of cancer development,” said Zheng. “I’m trying to understand the basic,
but very important question of how the Hh signal defines
cell-to-cell interaction, which is what I am going to focus on
with this grant.”
The project, titled “Hedgehog-mediated regulation of
cell adhesion,” will be funded over a three-year period.

M E D I C I N E + H E A LT H

5

Home Field

ADVANTAGE
Vice President and Dean
Jeffrey S. Akman employs
his gift for uniting people to
benefit the School of Medicine
and Health Sciences
by Steven Goldstein
photography by Michael Leong
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T

hanksgiving break, 1977. Jeffrey Scott
Akman, union leader’s son and Duke
University graduate, returns to his family’s
Baltimore home having just completed his first
few months of medical school at the George
Washington University.

His pleased parents and grandparents sit with him at the
kitchen table, filled with pride and expectation. His grandmother, Bubbe Rose, reaches into her ample pocketbook and
pulls out an assortment of pill bottles, perhaps 10 in all, and
asks: “So, Jeff, do you think I’m on the right medications?”
Akman laughs as he thinks back to the scene. “I’d been
in school for three months. But it struck me that it’s all part
of how people see you and treat you as a doctor, and it’s part
of the evolution of your own identity.”
So, years later, when a student approached Akman, by
then director of medical student education in psychiatry
and an assistant dean at GW’s School of Medicine and
Health Sciences (SMHS), and said that he’d figured out that
medical school was just a glorified vocational institution,
Akman encouraged him to reconsider. “You don’t realize how
you’ve evolved in your identity and your sense of yourself,” he
recalls telling the student. “I wanted him to understand the
developmental process that students go through when they
become physicians, how their confidence and their professionalism evolves.”
Akman’s own identity is inextricably tied to SMHS,
where he has been a student (M.D. ’81); a resident (G.M.E.
’85); a faculty member; an administrator; the Leon M.
Yochelson Professor and Chair of the Department of
Psychiatry and Behavioral Sciences; the interim vice president for health affairs and dean; and, as of January 2013,
the Walter A. Bloedorn Chair of Administrative Medicine,
vice president for health affairs, and dean. He arrived at the
school just four years after Ross Hall opened in 1973, and his
long experience with SMHS is a huge advantage in his new
role, he says.
“I know the DNA of the school. I know it from so many
different perspectives,” Akman says. “I know the culture and
the history, and when I think about my role as dean, all my
experiences are relevant.” During a recent trip to California,
Akman spoke with a 1970s-era alumnus who expressed the
hope that SMHS remains as supportive of its students today

as it had been in his experience. “I replied that not only am
I a product of that culture of collaboration, cooperation,
teamwork, and support, I feel like I’m the guardian of it,”
says Akman.
This does not mean that the dean’s stewardship equates
to running in place. At a town hall meeting after he took
office, Akman presented an ambitious list of priorities,
including increasing the number of scholarships; maintaining
tuition affordability; re-examining and revising the medical
education curriculum; helping GW advance as a top-tier
research university; enhancing diversity at SMHS; enlarging
the school’s footprint internationally, especially in China;
finishing the renovations to Ross Hall and planning for a
new building; increasing space for teaching and labs at GW’s
Virginia Science and Technology Campus in Ashburn; and,

“I know the DNA of the school. I know it from so
many different perspectives,” Akman says. “I know
the culture and the history, and when I think about
my role as dean, all my experiences are relevant.”
finally, revising the strategic plan as soon as new leadership
appointments are finalized. An expansive agenda, to be sure.
At the same meeting, Akman commented that it was
“kind of nice” to have a psychiatrist in the dean’s office.
Although the remark drew knowing laughter, he was only
half joking. “As a psychiatrist, you’re trained to deal with a
range of personalities and group dynamics. You’re trained to
listen carefully,” he says. “You have to be a leader and also to
communicate your vision and priorities, but ultimately if you
want change to occur, you have to get buy-in — and being a
psychiatrist helps with that.”
When the search process began, says GW President
Steven Knapp, he and Provost Steven Lerman were looking
for a candidate who ideally had “the leadership and people
skills necessary to serve as an ambassador for the university.”
M E D I C I N E + H E A LT H
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“This is a particularly complex role,” explains Knapp.
“Not only does the position entail all of the responsibilities
and requirements of academic leadership as dean of a professional school, but also the vice president for health affairs
serves as the liaison between the GW Hospital, the GW
Medical Faculty Associates, Children’s National Medical
Center, and the VA.”
In the area of building consensus, Akman has had some
strong influences in his life. As the son of a union leader, he
holds vivid memories of union halls packed with hundreds of

Akman shares the excitement and joy of match day
with members of the SMHS Class of 2013.

workers, and watching as his father spoke, persuading them
to accept or reject a contract. When Akman first became
interested in medicine as an undergrad at Duke, his father’s
cousin, Leonard Akman, M.D. ’43, a cardiologist who graduated from GW, gave him his first microscope. There was
also former Dean Robert Keimowitz, M.D., who encouraged
his choice of psychiatry, as well as other faculty members,
including the late Winfield Scott, Ph.D., who mentored
Akman and in 1988 recommended him for the board of the
National Lesbian and Gay Health Foundation.
Akman was living in one of the hardest-hit areas of the
HIV/AIDS epidemic in the early 1980s, and his work with
the then fledgling Whitman-Walker Clinic and his treatment of HIV/AIDS patients is an enduring part of a medical
career that has led to numerous honors, such as his selection
by Washington, D.C., Mayor Vincent Gray to serve on the
city’s Commission on HIV/AIDS. Akman also sees HIV/
AIDS as an important research area on which to build; he
recently hired Douglas Nixon, M.D., Ph.D., an internationally recognized HIV/AIDS researcher from the University of
California at San Francisco, to chair the SMHS Department
of Microbiology, Immunology, and Tropical Medicine.

8 GWMEDICINEHEALTH.COM • S P R I N G 2 0 1 3

He vividly recalls his early experiences as a clinician facing the burgeoning epidemic in 1984. Akman had
a patient, a man in his 20s who was a photographer, who
announced that he was suicidal. “He came into the hospital
with an IV in his arm, as he was receiving intravenous treatments at home. He could have committed suicide if he really
wanted to,” recalls Akman. “I learned that when patients say
they want to die, frequently what they mean is that they want
to live, and they are searching for hope. Despite his terminal
illness, he was able to work through the pain and many of the
losses he was dealing with. I learned a great deal from him.”
Akman has served as a willing role model for LGBT
students and those unsure of their sexual orientation. His
sense of inclusiveness prompted his friend and colleague
Seymour Perlin, M.D., GW professor emeritus of psychiatry
and behavioral sciences, to say that Akman “is an example
of what every mentor or tutor hopes will emerge from their
guidance and training. He possesses the gift of bringing
people together.”
That gift will help Akman in his service to the school’s
development office, which keeps him busy meeting alumni. “I
truly value alumni and the role they play in the school; among
other things, I’m prominently including them in special
events such as our white coat ceremonies and graduations,”
he says. One of Akman’s goals in the near future is to secure
a gift for the naming of SMHS, which will go a long way in
securing the school’s future.
“Set the bar high for medical and health sciences education, and our students will get there,” is how he expresses
his education philosophy. Akman has set lofty heights for
his own stewardship, and there is every expectation they will
be reached.

Keeping it all in perspective, Akman shares a light-hearted
moment with classmates during medical school.

Bopper Comes
Back to GW
By Laura Otto

L

awrence Deyton asks that you call him by his nickname, Bopper. After all, it’s what his family, friends,
and colleagues have always called him. “I didn’t
even know about the name Lawrence until I got
to junior high school,” insists Deyton. “My mother
and older sister sat me down and told me that Bopper was a
nickname given to me as an infant and the name just stuck.”
Whatever you call him, returning to the George Washington
University (GW) is returning home for Lawrence “Bopper”
Deyton, M.D. ’85, who has joined GW’s School of Medicine
and Health Sciences (SMHS) faculty as a clinical professor of
medicine. He will also serve as a professor of health policy at
the GW School of Public Health and Health Services.
Driven by his passion for a healthier United States,
Deyton brings to the university more than 30 years of experience in federal public health, health policy, health system
administration, and clinical research. Deyton held leadership
positions at the National Institute of Allergy and Infectious
Diseases at the National Institutes of Health for 11 years, and
served as the chief public health and environmental hazards
officer for the U.S. Department of Veterans Affairs’ Veterans
Health Administration. And in the 1970s he co-founded the
Whitman-Walker Clinic in Washington, D.C.
More recently, as the first director of the Center for
Tobacco Products at the U.S. Food and Drug Administration
(FDA), Deyton led the creation of the science, regulatory,
and enforcement foundation for implementing the Family
Smoking Prevention and Tobacco Control Act. The act was
signed into law by President Barack Obama on June 22, 2009,
becoming one of the president’s first major public health
accomplishments. Deyton led the implementation of rules
and regulations that prohibited marketing tobacco products
to children and adolescents; prohibited the manufacture and
sale of cigarettes with fruit or candy flavors; banned the use
of misleading descriptors (“light,” “low,” or “mild”); enacted
requirements for disclosure of tobacco product ingredients to
the FDA, and set the scientific standards for the introduction
of new or modified-risk tobacco products.
Being back at GW, Deyton is most excited about
engaging with students, trainees, and faculty. “I want to help

mold medical students into highly trained clinicians who
can also be leaders in health policy and public health,” says
Deyton. Last summer, Jeffrey S. Akman, M.D. ’81, G.M.E.
’85, vice president for health affairs and dean of SMHS, asked
Deyton to serve as the keynote speaker for the M.D. White
Coat ceremony. Honored by Akman’s invitation, Deyton
says the experience transformed him. “Walking up to that
podium in Lisner Auditorium, the very place where I took my
Hippocratic Oath, was an extremely powerful moment for
me,” he recalls.
So much has changed at GW since those days when he
was a medical student. The biggest difference, according
to Deyton, is the university’s growth. “When I came to
GW, where the GW Hospital is now was a parking lot and
the space that was the GW Hospital is now Whole Foods,”
recalls Deyton.
There is no doubt that Deyton is excited to be back in
the classroom. “Hopefully GW students can benefit from my
experiences in medicine, public health, and health policy,”
he said. “I want to encourage our trainees and faculty to take
full advantage of GW’s status as ‘neighbor’ to the White
House and the decision makers in the federal agencies,” said
Deyton. “It is great to be back home.”
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Hippocrates and the Essence of Euripides
Medical humanities education illuminates the human condition, creates more effective clinicians

I

By Steve Goldstein
n the film 50/50, based on a true story, a 27-yearold writer is blindsided by a cancer diagnosis and
struggles with the disease, as well as the bewilderment of his friends and family. James L. Scott, M.D.,
former dean of GW’s School of Medicine and Health
Sciences (SMHS) and a professor in the Department of
Emergency Medicine, teaches this movie in a film and
medicine course. “It portrays living with cancer in a way we
don’t normally think about, with a young man dealing with it
through black humor, with friends making fun of it, living with
it in ways that wouldn’t occur to most people,” says Scott.
And it fits in with the goals of humanities education at
SMHS, which is aimed at using the arts to deepen the understanding of the human condition. Or, to put it another way,
adding the essence of Euripides to the ethos of Hippocrates.
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Vice President for Health Affairs and Dean of SMHS
Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, an avid supporter of
the program begun by Scott in 2005, and himself a former
English major at Duke University, says: “I think the arts and
humanities give us particular insights into the human condition that are relevant to being a physician. I want to support my
students, residents, and faculty so that they think about people
in a complex way, and arts help us to do that. I think that’s what
drives people to medicine — the notion of humanity.”
GW holds a unique and prominent place in medical
humanities education in the United States. Although a
majority of medical schools offer some courses in medical
humanities, only a relatively small percentage offer as robust
a program as SMHS, according to Therese Jones, Ph.D.,
interim director of the Center for Bioethics and Humanities

at the University of Colorado, Denver. And the emphasis at
GW is growing.
“Medical humanities” is typically defined as an interdisciplinary field of humanities (literature, philosophy, ethics,
history, and religion), social science (anthropology, cultural
studies, psychology, sociology), and the arts (literature,
theater, film, and visual arts) and their application to medical
education and practice. Apart from providing insight into the
human condition, studying literature and the arts helps to
develop and nurture skills of observation, analysis, empathy,
and self-reflection — skills that are essential for humane
medical care.
Linda Raphael, director of the medical humanities
track curriculum at SMHS, emphasizes the interdisciplinary
nature of the program. “When any discipline sees itself as
separate from all other things, it tends to suffer,” she says.
“Medical education is very vigorous and demanding. The
humanities offer an opportunity for students to think and
talk about what they’re doing in a different language and
through different perceptions. It takes them a little back into
the world they’ve come from.”
At GW, medical humanities electives are offered in the
first, second, and fourth years. In the third year, Raphael
leads one to three sessions in all of the clerkships — psychiatry has three, for example. So even if a student chooses
not to take any electives, he or she will attend humanities sessions in the clerkship year. “By the fourth year, the
number of students exposed to classes in medical humanities
is at least one-third of the 170 students in each class,” she
says. There are also those who choose the humanities track
for all four years, although this cohort is small.
Raphael, who teaches a course on graphic literature
involving medicine called “Commix,” recalls a neurology
track student who was particularly moved after viewing a film
meant to stimulate discussion about the distinction between
sympathy and empathy. “She said it meant a lot to her to have
an opportunity to talk about these things,” Raphael says.
Another innovation at SMHS is a Theater in Medicine
program, developed by Charles Samenow, M.D., assistant
professor of psychiatry and behavioral sciences and director
for medical student education, and GW visiting professor
Jeffrey Allen Steiger, who directed a theater program at the
University of Michigan. A team of actors, some of whom
have a background in health care, use common issues such
as personal relationships, stress, and competitiveness among
practitioners to highlight theories of professionalism.
One performance, called “Milestones,” is a dynamic,
interactive multimedia production focused on professionalism,
burnout, and disruptive behaviors. Samenow believes that
information delivered through the medium of theater — “a safe
learning environment” — resonates with students and faculty,

and makes lessons on communications, conflict resolution, and
teamwork more vivid and, often, longer lasting. Feedback from
students and professionals has been very positive.
Psychiatrist and philanthropist Assad Meymandi,
who received his M.D. from GW in 1962, has been a vocal
supporter of humanities education at his alma mater. “The
most important thing for me is to bridge the gap between
basic sciences and the humanities and the arts,” he says. “I see
so many humanists who don’t know anything about science
and so many scientists who know nothing about the humanities. I want to bring the two bodies together.” Meymandi says
he’d love to add a course to the humanities curriculum about
“what it means to be a human.”

Samenow believes that information delivered
through the medium of theater — “a safe learning
environment” — resonates with students and
faculty, and makes the lessons on communications,
conflict resolution, and teamwork more vivid and,
often, more permanent.
Humanities education at GW is not restricted to medical
students. Christopher Bayne, a urology resident, is chair
of the Arnold P. Gold Humanism Honor Society chapter
(see page 32). “The Gold Foundation and others like it are
trying to bring the human element back into what is almost
algorithmic care,” he explains. “Medicine used to be a very
personal interaction; now it’s not.”
Akman spends significant time speaking to alumni and
potential donors about supporting the humanities education program. He is proud of the humanities history at the
school, which he says actually began with popular professor
Frank N. Miller, B.S. ’43, M.D. ’48, GW professor emeritus
of Pathology, who originated a Medicine in Literature
course way back in 1967.
Akman himself teaches a course with Raphael. A theater
buff, he was momentarily overwhelmed with ideas when
asked what play he would teach. “Angels in America by Tony
Kushner,” he reasons. “It deals with HIV/AIDS, and he
builds an epic play around a medical illness.
“If I could have medical students see one play, that
would be it.”

>> On the web
Scan this QR code with any mobile device for
related content — available online below the story.
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Comparative Speaking
Clinical Research and Leadership Professor Shawneequa Callier, J.D., M.A.,
weighs in on the implications of human genome research
By Kristin Hubing

I

n the summer of 1996, the scientific community was
stirring with the news of the birth of Dolly the sheep
— the first mammal to be cloned from an adult cell.
Shawneequa Callier was still a high school student in
Queens, N.Y., at the time, but she was already captivated by
the ethical concerns that arose from this breakthrough.
During her freshman year at Princeton University,
Callier enrolled in her first bioethics course. It was taught
by renowned political scientist and philosopher Amy
Gutmann, Ph.D., who now serves as chair of the Presidential
Commission for the Study of Bioethical Issues and president
of the University of Pennsylvania. “My most vivid memory
of any college professor is of Dr. Gutmann,” recalls Callier.
“She eloquently presented us with case studies and thought
experiments that trained us to think about transparency,
accountability, and ethical decision making. I continue to
admire her as an instructor and thought leader.”
Shawneequa Callier, J.D., M.A., assistant professor
in the Department of Clinical Research and Leadership
at the George Washington University School of Medicine
and Health Sciences (SMHS), has since dedicated herself
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to the study of the ethical, legal, and social implications of
human genome research. She says she “fell in love with the
field” as a graduate student interning at the World Health
Organization’s Human Genetics Programme in Geneva
(before that, Callier studied bioethics at Monash University
in Australia), where she had the opportunity to review international guidelines related to genetic research and the ethical
conduct of such research.
After stops at Georgetown University Law Center and
the Case Western Reserve University Center for Genetic
Research Ethics and Law, Callier joined the SMHS faculty
in the spring of 2011. She currently teaches online health
sciences courses in bioethics and health care law. Callier, a
self-proclaimed fan of social media, enjoys teaching online.
She utilizes discussion boards and reflection journals, and
says that “unlike in a classroom where five to 10 students
might speak all the time, I know what’s going on in every
single student’s head.”
She recently built a wiki (a website that enables users
to add or change content) for her bioethics class and asked
her students, many of whom are adult professionals already

working in health sciences, to contribute to a list of issues
they would want a patient to understand before donating
DNA to a biobank. “Teaching in a classroom is great too,”
Callier says, “but these students are leading very busy lives.
They want to get a degree while they’re also being leaders at
the office, and this is a great way to allow that.”
When she’s not teaching, Callier is immersed in her
research. As a co-investigator on a grant funded by the
National Human Genome Research Institute at the National
Institutes of Health, she addresses the ethical, legal, and
social issues raised in personalized medicine within the
context of comparative effectiveness research (CER).
“There is a potential conflict between CER and personalized medicine,” Callier explains. “CER aims to identify the
most efficient and effective strategies for treating the average
patient suffering from a particular disease, but personalized
medicine focuses on medical interventions tailored to fit each
person’s unique genetic profile. Ideally, the two will evolve
together so that providers can place patients into subgroups
and then pinpoint the most cost-efficient strategies for each
person within those subgroups.” Two graduate students
from GW’s School of Public Health and Health Services,
Rachel Simpson and Monica Gonzalez, assist Callier with
her research on this grant, as well as her work as one of three
principal investigators evaluating providers’ use of race and
genetics in medical care.
According to Joseph Bocchino, Ed.D., M.B.A., senior
associate dean for health sciences, Callier’s work is essential,
given the important role that bioethics plays in how health
care will be shaped and delivered in the future. “Dr. Callier’s
contributions to SMHS will be particularly important as the
school engages in more health outcomes and comparative
effectiveness research,” Bocchino says. “Also, her passion for
this field is now being transferred through her classroom to
the next generation of health practitioners and researchers.”
Callier is deeply concerned about gaps in research that
limit our understanding of genetic contributions to disease
globally and therefore our understanding of the role of
rare mutations domestically. This unease prompted her to
co-author an article titled “Why personalized medicine
will fail if we stay the course,” which was published in the
November 2012 issue of the journal Personalized Medicine.
Callier’s other recent publications include “GINA and
preemployment criminal background checks,” which is a
Hastings Center Report piece about the Genetic Information
Nondiscrimination Act, and a target article in The American
Journal of Bioethics about whether universities should be
allowed to facilitate educational DNA testing.
Currently, Callier is also collaborating with investigators at the National Human Genome Research Institute
and at universities in Africa who share her interest in the
just and equitable distribution of the benefits of genomic

research. “I’m co-authoring a manuscript now with another
Georgetown Law alumna who lives in Nigeria. We’re evaluating legal issues raised by genomic research in Nigeria and
assessing the role of local laws and customs,” she says.
Callier sees herself evolving in the genetic research
world, but can’t imagine ever leaving it. She is currently
following the
Maryland v. King
Supreme Court case,
which addresses
whether the Fourth
Amendment
allows states the
right to collect
and analyze DNA
from those who
have been arrested
and charged with
serious crimes. “I’m
collaborating with
a colleague at the
Center for Research
on Genomics and
Global Health on a paper about what it takes to qualify an
expert witness on genetic testing,” Callier says. “Given the
rapid advancement of genomic technology and the simultaneous controversies raised by the regulation and reliability of
genetic testing services, debate about the utility, validity, and
safety of gene-based, medical decision making will eventually
find its way into the courtroom.”
When it comes to the regulation of genetic research,
Callier says she is a fan of information, education, and
dialogue. “I don’t think we can really know what the regulations should be until we have a conversation with the people
who are going to be impacted by those regulations,” she
says. “Experts who study the consequences of these technologies should interact with the people who are going to
be affected by the technologies. We have to protect the
informed consent and the health and safety of every single
person we involve in research, but we want to have an idea of
the community’s needs and we want to make sure we address
them as we pursue research.”
Throughout it all, Callier remains grateful for the
support of her colleagues at GW. “I’ve moved around quite a
bit, and this is one of the first times where I feel like I’m in
the right environment,” she says. “And that’s kind of cool.”
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Jumping to Solutions
Researcher Sally Moody uses frog embryos
to clear the knowledge gap in neural regeneration

S

By Steve Goldstein

ally A. Moody is a lab rat. She works with
frogs in service to the world’s mammals,
especially the two-legged kind. If her
research at GW reaches its full potential,
it will mark a significant breakthrough in
neural regeneration through the manipulation of stem cells.
Sally Moody, Ph.D., a professor of
anatomy and regenerative biology at the
George Washington University School of Medicine and
Health Sciences, is currently exploring the cascade of interactions that instruct lineages to give rise to the frog nervous
system. In collaboration with fellow GW professor and

Working with a gene called
FoxD4 in Xenopus laevis, the
African clawed frog, Moody and
her team wanted to influence a
cell that would otherwise make
gut or skin to instead make
nervous system.
GW Institute for Neuroscience Director Anthony-Samuel
LaMantia, Ph.D., Moody is trying to determine whether
what she has learned about manipulating a gene in the frog
embryo is applicable to mouse embryonic stem cells.
The 60-year-old personable, tattooed (yes — more on
that later) former music major, who grew up on a dairy farm
in upstate New York, is celebrating the 30th anniversary of
her lab, which she began at the University of Virginia as an
assistant professor. To fully appreciate Moody’s dedication
to her lab, let’s reflect on the story of Max Mandelbaum.
Last year, Mandelbaum, an eager GW freshman from the
Philadelphia suburbs, signed up for a stem cell course that
Moody was offering. Unfortunately, he was the only enrollee,
so Moody offered him a choice of dropping the course or
taking a one-on-one seminar with her each Wednesday.
Mandelbaum was amazed. “I think most professors
would have just canceled the course,” he said later.

One Wednesday, Mandelbaum found Moody’s office
door locked. “I had simply forgotten,” she explains, “so he
tracked me down in the lab.” Moody explained she was
working with frog embryos and the student was enthralled.
And that’s how Max Mandelbaum became one of three
undergrads now working for credit in her lab. “I’m trying
to get him a grant so he can work in the lab this summer,”
Moody says. “He’s very gung-ho.”
Mandelbaum says his career path has changed. “I was
originally focused on med school,” he says, “but the more I
work in her research lab, the more I’m thinking of getting a
Ph.D. and pursuing my own research.”
Moody spends a lot of time with her undergrads, teaching
them how to do research and working with them at the bench.
“I really enjoy this,” she says. “I had a similar experience as
an undergrad doing independent research — once I figured
out I wanted to do biology.” In fact, if not for her wanting
to escape rural New York and having a lack of confidence
in her own musicianship, the world might have lost an
eminent researcher.
Her desire for independence led Moody to leave high
school after her junior year after being accepted early by
Goucher College in suburban Baltimore. Halfway through
her second year, Moody says, she “realized there was no way
I was ever going to make a living as a music major because
I wasn’t that good.” The longtime self-described “science

>> On the web
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nerd” switched to biology and again graduated after only
three years. Seeking financial independence, Moody finally
landed a job as a lab tech in the anatomy department at the
University of Maryland School of Dentistry. “They taught
me to do histology and I loved it,” she says. “And they asked
me if I wanted to get a master’s because they saw how interested I was.”
Moody did research in neuroscience under the tutelage
of Richard Meszler, Ph.D., and her career path exploring
the nervous system was launched. She earned her Ph.D. in
neuroscience from the University of Florida and served a
M E D I C I N E + H E A LT H
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Moody is looking for a method to control the gene expression
of embryonic cells to encourage them to make neurons that
could be used to replace damaged brain tissue.

postdoctoral fellowship at the University of Utah until
1983. She then went to the University of Virginia and
served on the faculty of the Anatomy and Cell Biology
Department, the Department of Neuroscience, and the
Developmental Biology program. She came to GW as a full
professor in 1994.
So what goes on in her lab? Moody and her team are
working on two grants from the National Science Foundation
and the National Institutes of Health. Working with a gene
called FoxD4 in Xenopus laevis, the African clawed frog,
Moody and her team want to influence a cell that normally
makes gut or skin to instead make nervous system. “What
we’re trying to do is understand how an embryonic cell makes
the decision to become a neuron,” she says. “It doesn’t have to
do with the frog’s nervous system; the frog is just the medium
in which it’s easiest to do the experiments. When they start
out, embryonic cells are pluripotent — that is, they can make
lots of different tissues. So it’s those early decisions we’re
trying to parse out, really looking at a network of genes and
how they interact to cause this conversion of a cell that can
make anything to a cell that can only make nervous system.
That’s pretty cool.”
The collaboration with LaMantia’s lab “grew out of our
shared interest in the early steps of specifying neural stem
cells,” says LaMantia. “Sally had done pioneering work on
a family of genes, the forkhead or Fox genes, that she had
shown clearly were key for neural stem cell identity in the
frog. My colleagues and I found that the mouse equivalent
of one of these genes had a dramatic increase in expression
just as the forebrain — the part of the embryonic brain that
will make all of the regions that do the ‘heavy lifting’ of
cognition, learning, and memory — becomes distinct as a
defined region. I think we really have been able to establish
16 GWMEDICINEHEALTH.COM • S P R I N G 2 0 1 3

an approach that will allow us to begin to sort out just what
the ‘switches’ are that direct a stem cell to become a neural
stem cell.”
Also in Moody’s lab, research scientist Bo Yan,
M.D., Ph.D., professor of Anatomy and Cell Biology and
of Genetics, is working on a two-year grant from NIH’s
National Institute of Dental and Craniofacial Research, for
its project on identifying novel genes involved in neural tube
and craniofacial birth defects.
If the research gods smile upon Moody’s work, scientists will be able to control development of embryonic cells,
whether they are in an embryo or a stem cell, and to force
them to make neurons in a controlled way. “We want to
control their gene expression so that they make neurons,
which would be useful for regenerative medicine,” says
Moody. “This could be used to replace neurons in damaged
neural tissue, as occurs in stroke — to grow replacements
and then transplant them. It’s a long way off, but that’s the
ultimate goal.”
Throughout her research, Moody continues to teach — in
school, in her lab, and outside the university. Not long ago,
she was giving a talk at an elementary school not far from the
Rockville, Md., home she shares with her husband, Steven
L. Klein, an NSF program director. Moody was wearing
sneakers with low-cut socks, and suddenly one of her young
listeners burst out: “Oh. My. God. She has a frog on her leg!”
Moody raised her pant leg above her right ankle, so
everyone could see. Sure enough, it was a blue-ink tattoo of
Xenopus, the product of a mother–daughter bonding experience with daughter Rachel at a Gaithersburg tattoo parlor.
Some folks wear their heart on their sleeve, metaphorically. Sally Moody carries visible testimony of her devotion to
research with every step she takes.

Physical Therapy on the Brain
GW’s Health Sciences Programs Prepare to Launch PT Neurologic
Residency Program
by Kristin Hubing

W

hen Elizabeth Ruckert graduated from Ithaca
College with her Doctor of Physical Therapy
(DPT) degree in 2006, she immediately accepted
a job at a rehabilitation hospital in New Jersey,
where she joined the traumatic brain injury rehab team.
After just six months at the hospital, she began to question
her decision. “I was feeling like there was so much I didn’t
know, and I was realizing how hard it was to have structured,
dedicated mentorship in this fast-paced health care environment,” she says. That’s when she began investigating physical
therapy residency programs.
There were only two neurologic residency programs in
the country at the time, and Ruckert chose to apply to the
one at the University of Southern California (USC). She was
accepted and spent the next year at Rancho Los Amigos
National Rehabilitation Center, USC’s partner facility, where
her foundational knowledge of neurologic practice and her
clinical skills were further developed and refined through
expert mentorship. The residency program also involved
teaching in USC’s DPT program and conducting research
in the school’s Neuroplasticity and Imaging Laboratory.
“Each component of the residency program helped me attain
a greater understanding of what comprises expert physical
therapy practice. These experiences set the foundation for my
path toward a future career in academia,” Ruckert says.
Ruckert, DPT, PT, NCS, GCS, now assistant professor
in the Physical Therapy (PT) Program at GW’s School of
Medicine and Health Sciences (SMHS), still cherishes her residency experience. So much so, in fact, that she is working with
leadership in the Physical Therapy Department to develop a
neurologic residency program here at SMHS in collaboration
with the MedStar National Rehabilitation Network.
In accordance with the American Physical Therapy
Association’s (APTA’s) strict credentialing requirements,
a one-year pilot of the residency program will commence
in August 2013. “Our mission is to develop neurologic
specialist practitioners who demonstrate advanced clinical
reasoning, assessment, and intervention skills for individuals
with neurologic disorders across practice settings,” Ruckert
says. The program will offer “very focused experiences and
mentorship in neurologic physical therapy practice,” much
like the experience offered in SMHS’s orthopedic residency
program, which has existed in partnership with Johns
Hopkins University since 2012.
Joyce Maring, Ed.D., DPT program director and
associate professor at SMHS, notes that the field of physical

therapy, like health care
in general, is becoming
more complex. “In order
to provide the best-quality
services, you really need
practitioners and leaders
who have advanced
qualifications to be able
to address the needs of
a particular population,”
Maring says.
Neurologic physical
therapy focuses on the
evaluation and treatment of individuals who have movement problems as a result of disease or injury of the nervous
system. “We’re movement dysfunction specialists,” Ruckert
says. “The goal is to maximize someone’s return to function,
to life roles.”
The challenging curriculum requires residents to
immerse themselves in different components of neurologic
specialty practice. The program has four primary focus areas:
clinical practice, teaching, research, and didactic education.
The residents — ideally there will be two during the pilot
year — will be responsible for treating patients for 20 hours
per week. The first four months will be spent on acute care,
the second four months on acute rehabilitation, and the final
four months on outpatient rehabilitation.
They will also have a clinician mentorship, which
Ruckert calls the hallmark of the residency program. “It’s
focused time with a neurologic rehab specialist,” she says. “It
gives the resident the opportunity to ask any questions they
might have and engage in higher-level discussion related to
clinical decision making, problem solving, and reflection.”
In addition to getting exposure to the entire health
care continuum, the residents in the program will also have
teaching opportunities within SMHS’s DPT program.
Ruckert stresses the importance of including a teaching
component in the model because “teaching requires synthesis
of information at a much higher level. That’s very important
to the development of a specialist’s understanding.”
Ruckert has a palpable enthusiasm for expanding
postgraduate education opportunities for new PT. “These
programs are so important to the development of our new
clinicians,” she says. “I’m impassioned about finding ways to
let other people have the same opportunities that I feel so
privileged to have had.”
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Where seizures freeze
At GW, bridges between the clinic and the bench
may revolutionize epilepsy care
18 GWMEDICINEHEALTH.COM • S P R I N G 2 0 1 3

By Amy Maxmen

W

hen Carrie Morgan1 turned 10
years old, she learned she had a
seizure disorder. For the next 28
years, she would try to calm the
intense and sudden attacks with
every anticonvulsant in the book.
Nothing worked; the seizures
grew more frequent. By 2000, she was suffering as many as 10
seizures per day. “My life was so restricted,” Morgan recalls.
“I went from neurologist to neurologist, and they would just
give up on me.” Then, Morgan met Samuel Potolicchio, M.D.,
the director of the Neurophysiology Center at the George
Washington University Hospital (GW Hospital). He told her
that by surgically removing a portion of her temporal lobe, the
region of the brain where the seizures originated, he might be
able to put an end to her attacks.
Taking out a piece of the damaged brain is a scary proposition, but not as scary as a life with uncontrolled seizures.
Before committing to the surgery, however, the team needed
to determine which side of Morgan’s brain dominated her
verbal memory recall. Potolicchio and Anthony Caputy, M.D.,
professor and chair of the Department of Neurosurgery, had
to confirm which sides of the brain had good or poor memory
recall. More importantly, however, they needed to confirm
that the side opposite of where the seizures were focused
had good recall. To do that they performed the WADA test,
named after Canadian neurologist Juhn Atsushi Wada, to
determine the language and memory dominance between the
hemispheres of the brain.
The team anesthetized the right side of Morgan’s brain,
and they asked her what Dr. Potolicchio held in his hand.
“A pen,” she correctly answered. When he anesthetized
the left side, Morgan recalls, “I couldn’t say what he was
holding. I understood, but I just couldn’t say it.” Immediately,
Potolicchio told her she an excellent candidate for the
procedure, and that her WADA test results confirmed that
she was quite safe in terms of her memory. Shortly after her
38th birthday in 2001, Caputy performed surgery. She has not
experienced a seizure since then, moreover she no longer takes
medications to control her seizures, allowing her to fulfill her
dream of graduating from college and becoming a medical
technician. “I now have a new lease on life,” she says.
One-third of people with epilepsy cannot control their
seizures with ordinary anti-epileptic drugs. Like Morgan in
her teenage and young adult years, people with untreatable
epilepsy are often barred from normal activities like swimming or driving because they frequently lose control of their
bodies. Unlike her, a subset of these patients are not able to
be treated through surgery. Neurologists and neuroscientists
at George Washington University (GW) find this outcome
terribly troubling. The Epilepsy Center at GW Hospital has

1

long helped those patients, and now it aims to do even better
by translating cutting-edge science into patient care. For
example, GW recently installed state-of-the-art equipment
to monitor brain activity, which will help doctors pinpoint
the origin of seizures so that they can tailor treatment to the
individual. What’s more, collaborations between clinicians
and researchers focused on the brain across the GW campus
promise to usher in a wave of new and personalized seizure
treatments in the years to come.
“My vision for the center is to be at the forefront of
utilizing the most advanced technology for the care of individuals with epilepsy, to be at the forefront of research, and to
be a leader in epilepsy education,” says Mohamad Koubeissi,
M.D., a neurologist directing the center. “Luckily,” he adds,
“these objectives are interwoven.” Indeed, translational
research requires an ever-flowing partnership between the
scientists at the bedside and the bench.

A Planned Attack
Koubeissi’s interdisciplinary attack resonates among his
colleagues at GW, as does his sense of urgency. “Only frequent
dialogue between clinicians and basic scientists can make
inroads into the big problems that have prevented cures for
epilepsy thus far,” says Anthony LaMantia, Ph.D., director of
the GW Institute for Neuroscience (GWIN).
Methods to intervene with epilepsy have stalled in part
because the brain is such a complicated organ to observe and
manipulate. However, new technology that can image and
monitor brain activities, and improved tools for analyzing
the genes that reveal a risk of epilepsy and drug toxicity, may
foster the next wave of advances. To this end, the center’s
new system for monitoring the electrical activity in patients’
brains does not require patients to remain in their beds with
wires connecting sensors on their scalps to computers at their
bedsides. Now, the sensors wirelessly communicate with a
hospital computer, meaning patients may be monitored more
comfortably for longer periods. With this additional electroencephalogram (EEG) data, neurologists can more accurately
predict where seizures arise in a person’s brain, and whether
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that person may be amenable to surgery or another investigational option.
People who are not safe candidates for surgery may soon
seek solace at GW too. GW has been exploring memory
loss for several years with other researchers on campus,
including GW’s Department of Psychology in the Columbian

The name has been changed to protect the patient’s identity.

M E D I C I N E + H E A LT H

19

College of Arts and Sciences. Koubeissi is investigating
a couple of procedures that may avoid memory loss. One
involves short-circuiting the seizure-generating section of the
brain by snipping connections between it and neighboring
regions. The second procedure is to electrically stimulate
the malfunctioning area in order to get its signaling back on
track. Through clinical trials to test these procedures at the
GW Epilepsy Center, patients with no viable options would

Partners without boarders. Matthew Colonnese, Ph.D.; Judy Liu,
M.D., Ph.D.; and Mohamad Koubeissi, M.D., form an information
exchange that moves data from clinic to lab as well as lab to clinic.

be offered the opportunity to try something new. “Following
the textbook, we currently tell these patients, I’m sorry,
there’s nothing we can do; you will live with your seizures,”
Koubeissi says. “In the future, we want to explain that we’ve
done everything in the textbook, but there may be procedures
we can offer that might help you without interfering with your
memory.”

Back in the Lab
For many years GW and the Department of Neurosurgery has
been a leader in the exploration into procedures using electrical pulses, called deep brain stimulation. Continuing in that
tradition, Koubeissi is investigating his own techniques into
the procedure. In preparation for the trials he hopes to soon
lead, Koubeissi is refining new methods of delivering electrical
pulses using rats with epilepsy. He studies them in his laboratory in GW’s Institute for Neuroscience. “People talk about
moving findings from the lab to the clinic, but it works both
ways,” Koubeissi says. “It’s clinic to lab, lab to clinic. It’s this
type of dynamic relationship that we want to foster at GW.”
Judy Liu, M.D., Ph.D., assistant professor of pediatrics at
the GW-affiliated Children’s National Medical Center (Children’s National) and member of its Center for Neuroscience
Research, operates in a similar manner. She focuses on the
neurological disorder lissencephaly, in which a person’s brain
cells do not migrate to the correct spot during early childhood. By age 10, children begin suffering from seizures and
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mental disabilities. Various mutated genes underlie the disorder, and Liu learns how these genes affect neuronal migration
by altering them in mice, and analyzing the downstream
changes in proteins that occur. “If we can figure out which
proteins become dysregulated in the mice,” Liu says, “we can
think about trying to alter proteins in patients in order to
counteract seizures.”
Liu’s laboratory work also focuses on samples from
patients, which ensures that what she discovers in mice is
applicable to humans. Liu collaborates with neurologists at
Children’s National. Weekly, she and the neurologists gather
to discuss difficult cases, including any children who might
go to surgery to ameliorate their epilepsy. When surgeries are
performed, Liu, or a member of her laboratory, heads to the
operating room to learn more about the patient and to observe
exactly which part of the brain the neurosurgeons remove.
They then cart the extracted tissue back to Liu’s laboratory
for analysis. “We usually find that the tissue is more prone to
[electrical] excitation, and we examine which genes are on and
off compared to normal brain tissue,” Liu explains. “Next, we
recapitulate those changes in mice so that we can understand
the problems those genes cause.” Soon, Liu hopes to collaborate with neurologists at the Epilepsy Center to examine adult
brain tissue.
Neurologists at the Epilepsy Center already converse with
GW’s neuroscientists on a regular basis. Recently, Koubeissi
helped Matthew Colonnese, Ph.D., an assistant professor at
the GWIN, understand patterns he saw in an EEG from a
rat brain. Colonnese studies the erroneous brain development that occurs in the genetic disorder Fragile X syndrome.
In humans, the disorder is a common cause of epilepsy and
mental disability, but parents often do not detect that their
child has the disorder until they are at least 2 years old. If
scientists could pinpoint when neurons begin to misfire during
a baby’s development, Colonnese suspects they might develop
a way to intervene before the problem becomes irreversible. To
learn when the problems begin, Colonnese experiments with
rats, engineered by an outside firm to bear a similar genetic
mutation, observing them as they develop Fragile X syndrome.
He has already had promising results: Before the rats showed
any behavioral signs of having Fragile X syndrome, Colonnese
noticed that some of their EEGs looked different from the
EEGs of normal rats. “I saw crazy activity patterns, and so I
asked Mohamad [Koubeissi] to look at the graph,” says Colonnese. “He pointed to a spike followed by a wave of activity and
described the type of seizure it was.” Although the baby rats’
muscles were not seizing up, the rats were enduring the first
neurological components of seizures.

Bridge Builders
Translating findings from the laboratory to the clinic begins
with interdisciplinary collaborations like these. To facilitate

those interactions, clinical and neuroscience departments host
seminars, and the Epilepsy Center hosts a monthly series of
lectures by epilepsy experts from around the world. In addition, GW researchers can conduct their brain-related experiments in a well-stocked core facility located at the GWIN
(see sidebar). Henry Kaminski, M.D., the chair of GW’s
Department of Neurology, trusts that basic findings will move
to the clinic at GW because the heads of each component
actively push for translation. “I meet with scientists and clinicians in other departments spontaneously because I want to
promote this type of interaction,” Kaminski says.
Kaminski suggested expanding the Epilepsy Center in
2011 for several reasons. First, he knew that top neurologists
and neurosurgeons at the center recognized the importance of
research in finding new treatments, and therefore, that they
might interact with neuroscientists like LaMantia elsewhere
on the GW campus. Second, Kaminski and GW Hospital’s
clinical partners appreciated an unmet need for the Epilepsy
Center in the greater Washington, D.C., area. “GW is among
the few places that patients with difficult cases can go,” says
Kaminski.
“We have the opportunity to establish a continuity
between pediatric neurology at Children’s National and adult
neurology at GW,” says Vittorio Gallo, Ph.D., professor of
pediatrics and of pharmacology and physiology at GW, and
the Wolf-Pack Chair in Neuroscience and director of the
Center for Neuroscience Research at Children’s National.
The collaborative work between Colonnese, Koubeissi,
and Liu, adds Gallo, is a prime example of how investigators can find colleagues whose research interests interface
with their own. That exchange, adds Gallo, goes both ways.
Normally, he says, research flows from basic science questions
to translational research and ultimately ends up as clinical
applications. “What we are able to do in this setting is reverse
that pipeline. Physicians are able to find partnerships to study
mechanisms that are at the basis of therapeutic applications
by working together with investigators who are using animal
models of disease.”
One of the greatest medical challenges of the 21st century
is finding cures for brain disorders. Neurological problems
have been nearly impossible to solve because the brain is difficult to study and difficult to treat. Despite these hurdles, the
army of clinicians and researchers across GW are well positioned to make a serious dent in the toll that seizures take on
patients. On their side are modern medical and scientific tools,
the push to interact across sectors, and raw drive. “As a doctor,
I got tired of telling patients and their parents, we don’t know
why these seizures happen and we can’t tailor our therapy to
you or to your child,” Liu says. “That’s why a lot of us are back
in the lab, so that five to 10 years down the road we can target
therapy to specific patients.”

Core strength
Collaborative research is engineered into the Institute
for Neuroscience. At the institute’s Biomarker
Discovery and Analysis Core Facility, researchers
from the Neurology Department as well as myriad
other centers across the GW campus gather in search
of molecular biology services, tools, and expertise.
There, researchers can have the DNA within their
samples analyzed with high-throughput polymerase
chain reaction platforms, microarrays, and in situ
hybridization. Alternatively, they may visit the core
facilities to conduct experiments that involve fluorescence microscopy; transgenic animals, plants, and
bacteria; or embryonic stem cells from mice. This
consolidation of resources saves money for individual
laboratories on campus because they do not need to
purchase their own equipment from scratch. In addition, it allows investigators to pursue questions outside
their laboratory’s—and often their department’s—reach.
Finally, it offers investigators from disparate realms
a place to collaborate. “You can’t force people to do
things together, but you can provide opportunities
that enable people with a variety of interests to cooperate,” says Anthony LaMantia, Ph.D., director of the
GW Institute for Neuroscience.
Much of the work conducted at the core facility
applies directly to biomedical issues. For example,
Thomas Maynard, Ph.D., director of the facility, uses
tools at the core to analyze changes in gene expression that result in seizures, learning disabilities, and
other symptoms of DiGeorge syndrome. Scientists
know that the syndrome is caused by a DNA deletion in a part of the human genome called 22q11.2;
however, they do not yet understand how this defect
disrupts protein networks to cause neurological
problems. Maynard’s findings unexpectedly aided
Irene Zohn, Ph.D, of Children’s National Medical
Center, when she visited the core facility to learn
which genes and proteins caused neurological
defects in malformed mice embryos. Maynard and
Zohn realized that a protein from Maynard’s experiment on DiGeorge syndrome, the nutrient retinoic
acid (or vitamin A), also went awry in Zohn’s embryos.
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A Call
to Arms
National tragedies
prompt health care
leaders to move
mental health to
the forefront
By Thomas Kohout

A

t 9:40 a.m. on Dec. 14, 2012, a troubled
20-year-old walked into Sandy Hook
Elementary School and gunned down 20
children and six adults. The tragic event
followed a pattern of 16 similar events
that year, crisscrossing the nation and
leaving 88 men, women, and children
dead. The horrible nature of the crime
reignited a long-simmering debate over access to guns,
weapon types, and the capacity and availability of ammunition magazines.
Just a few days removed from the events, however, Kurt
Newman, M.D., president and CEO of Children’s National
Medical Center (Children’s National), and professor of
surgery at GW’s School of Medicine and Health Sciences
(SMHS), raised his voice to offer a new focus to the discussion — pediatric mental health.
The tragedy in Newtown, Ct., offered the opportunity
to draw attention to an issue Newman and other health care
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professionals believe is long overdue. Immediately following
the incident, issues involving guns and gun violence were
on everyone’s lips. “While that’s probably appropriate, it’s
almost entirely an after-the-fact approach,” says Newman.
“There is another big dimension to this, and that is the
mental health of children.
“To me, it doesn’t feel like our country is focused on
kids’ mental health — pediatric mental health is not being
addressed in the same way we address other diseases,”
explains Newman.
Soon after, Newman penned an editorial, titled “The
Treatment of Mental Conditions Must Start Early,” which
was published in the Dec. 27 edition of The Washington Post.
In it, he outlined the scope of the problem and offered several
steps for addressing gaps in pediatric mental health care and
thereby securing a better future for the nation’s children.
First among Newman’s recommendations was to take
a moment to simply accept the magnitude of the problem.
Shooting incidents like the ones that occurred at Sandy

Hook, Virginia Tech, and Columbine High School paint
a picture of pediatric mental health in the extreme. The
real tragedy, he argues, is in the scope of the issue, not the
severity of a few iconic cases. According to the National
Institute of Mental Health, one in five children in the United
States suffers from a mental health-related problem; of the 15
million children affected by such conditions, only 20 percent
ever receive treatment.
Such an outsized figure might seem farfetched, explains
Paramjit T. Joshi, M.D., professor of psychiatry and behavioral sciences at SMHS, director of psychiatry at Children’s
National, and president-elect of the American Academy of
Child & Adolescent Psychiatry, but that is because public
attention is often drawn to more intense mental health
disorders such as schizophrenia. “Among the 20 percent of
children with a mental health diagnosis, roughly 5 percent
have a serious mental health condition,” says Joshi. The
majority of cases “experience an array of difficulties that are
very treatable, such as depression, anxiety, eating disorders,
and ADHD.”
The key to addressing the mental health needs of
children and adolescents is early screening. As with any
other illness, making an early diagnosis often leads to better
outcomes. Therefore, it is very important to identify children
who either are at risk or may already be exhibiting some
symptoms of these disorders. Although externalizing disorders such as ADHD and oppositional defiant disorder come
to adult attention readily, says Joshi, internalizing disorders
such as anxiety or depression do not. “You don’t see it, but
children feel it.” Most children with internalizing disorders
might never be diagnosed, especially if they have no overt
behavioral difficulties. If they are diagnosed, often there is a
long delay between symptoms and identification.
The average length of time between when a child begins
experiencing symptoms and diagnosis and treatment is
between eight and 10 years, according to Newman. By that
time, the child is well on the way to becoming an adult, when
behaviors become more entrenched. “If we could move that
timeline forward,” he says, “we could get them into treatment
sooner and we could have a major impact on their long-term
quality of life — and the safety and health of our larger society.”
Enlisting aid from the basic sciences is another area
where Newman sees hope for solutions. Discoveries in
genetic research have already begun to transform the landscape for cancer and metabolic disease treatment, and both
Newman and Joshi see discoveries in genetics and predictive
or anticipatory medicine as offering the potential for very
individualized diagnosis and treatment in the future.
As is the case in every discussion about health care,
access to care is the linchpin that holds together any plans
for improvement. In many ways, the United States is ahead of

the rest of the world in terms of pediatric mental health care.
Among U.S. allied health professionals, there are nearly 8,700
child and adolescent psychologists, as opposed to roughly
400 in Canada. But, in a nation of almost 314 million people,
with children under age 18 making up about 24 percent of the
population, there are still huge gaps in coverage.
Even in a densely populated region like Washington,
D.C., Children’s National is the only pediatric emergency
mental health care facility in the area. Each month, more
than 200 children pass through its doors seeking emergency psychiatric care. “In terms of inpatient facilities,

According to the National Institute of Mental Health, one in
five children in the United States suffers from a mental healthrelated problem; and of the 15 million children affected by
such conditions, just 20 percent ever receive treatment.
Washington, D.C., has two facilities,” says Joshi. Children’s
National, one of those two inpatient facilities in the city, has
just 26 beds available; 12 beds for children under the age of 13,
and 14 beds for patients between 14 and 18 years of age.
Elsewhere in the country, she says, are states with no
psychiatric inpatient facilities for children and adolescents. In
those cases, patients are admitted to facilities in nearby states.
“You can just imagine how disjointed that makes the care,”
Joshi says. “The family is unable to participate in a meaningful
way because the child is so far removed.” And that, says Joshi,
can have serious ramifications for treatment outcomes.
Newman adds that it’s possible the health care system
needs to consider new models of care, such as co-locating a
mental health professional with pediatricians, or training
teachers or school nurses as virtual mental health care
first responders.
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“One of the issues that becomes apparent is that we
aren’t training enough people,” says Newman. “As a nation,
we aren’t educating enough health professionals and psychologists to deal with these great numbers.”
Partnerships like those between SMHS and Children’s
National have the resources, expertise, and inclination to
take a leading role in this national initiative. “That’s an
important role I think George Washington University can
fill. We need the research, we need the education, and we
need advocacy. In order to be effective, all of these assets and
the clinical care given to kids at Children’s National need to
move in parallel,” says Newman.
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Off the Hook
GW Researchers Close in on Hookworm Vaccine

It has been decades
since the last case
of hookworm was
reported in the United
States, but the intestinal
parasite still infects
more than 500 million
people throughout the
developing world.
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By Kristin Hubing

O

n the surface, the groundbreaking
research being performed by Jeff
Bethony, Ph.D., and David Diemert,
M.D., which involves bringing hookworm
back to the United States, may seem
counterproductive. But they’re well on
their way to developing a vaccine that could eradicate this
persistent tropical disease worldwide.
After more than 15 years of research, Bethony and
Diemert, both associate professors of microbiology, immunology, and tropical medicine at GW’s School of Medicine
and Health Sciences (SMHS), are currently conducting
first-in-human studies of two hookworm vaccine candidates,
Na-GST-1 and Na-APR-1. A vaccine for hookworm — a
disease that causes anemia and can lead to problems with
physical and cognitive development in children — could revolutionize the way it is controlled.
The current strategy is based on mass drug administration, an approach in which anti-worm drugs are given to all
children in endemic areas once a year. Diemert says that in
addition to being logistically challenging, the strategy is ineffective. “Kids get re-infected after they are treated,” he says.
“And there is evidence that the drugs become less effective
over time.”
For these reasons, Bethony and Diemert are focused on
developing a vaccine that would prevent serious hookworm
infections from occurring in the first place. Their unique
approach is to attenuate the nutritional process of the hookworm — effectively starving it out. “It’s a very new, novel way
of creating an anti-parasite vaccine,” Bethony says.
With support from the Sabin Vaccine Institute Product
Development Partnership (formerly known as the Human
Hookworm Vaccine Initiative), Bethony and Diemert are
developing the first challenge model that has ever been
done for hookworm. “This will allow for early assessment
of proof of concept,” Diemert says of the Phase 1 clinical
trial, which is proposed to take place at the GW Medical
Faculty Associates.
After undertaking a safety feasibility study with oversight from the U.S. Food and Drug Administration and GW’s
Institutional Review Board, the researchers will inoculate
healthy volunteers with their candidate vaccine. They will
then give the volunteers an effective dose of hookworm
larvae, which is transmitted through skin penetration, to test
for the protective effect of the vaccine.
“This will help us enormously as far as speeding up the
timelines for allowing decisions to be made as to which vaccine
candidates are the most promising,” Diemert says. There are
currently two vaccines in consideration, which they plan to
combine into a single product. Bethony adds that once this
model is established, “if any other hookworm vaccines come
along, this will be the basis on which they’ll test it.”

Although the U.S. “challenge” study is still more than a
year off, Bethony and Diemert have already begun a Phase
1 clinical trial of Na-GST-1 in the state of Minas Gerais in
southeastern Brazil, where they’ve been working in conjunction with the Ministry of Health since 2003.
There, they’ve built a lab and a clinic in partnership with
the Oswaldo Cruz Foundation (FIOCRUZ), which houses
a staff of more than 30 people, including clinicians, nurses,
regulatory affairs specialists, lab technicians, and researchers.
The Brazilian government, very supportive of the initiative,
recently gave FIOCRUZ a $1 million grant to conduct additional clinical trials of the hookworm vaccine.
Back in the United States, Bethony and Diemert are
excited to be making plans for the clinical trials to begin
at GW. “It’s a big step for us to do vaccine studies here,”
Bethony says. “It really integrates us. We use the whole
GW infrastructure and get to involve more faculty.” John

David Diemert, M.D.

Jeff Bethony, Ph.D.

Hawdon, Ph.D., associate professor of microbiology, immunology, and tropical medicine at SMHS, will be managing
the sampling of the pathogen when it arrives here in
Washington, D.C.
Bethony and Diemert are especially grateful for
the funding they’ve received for another Phase 1 trial of
Na-GST-1 from GW, through the Clinical and Translational
Science Award (CTSA) program. This study is currently
underway at Children’s National Medical Center and has
enrolled more than 20 healthy adult volunteers. “The pilot
funding from the CTSA has been critical,” Bethony says.
“It allowed us to establish a clinical structure, learn how to
recruit in D.C., and train our lab in how to receive samples
and work on human biomaterial.”
“It’s important in terms of vaccine development, too,”
Diemert adds. “We’re testing different formulations and
different ingredients to see if we can fine-tune immune
response. It’s contributing to us being able to make a
better vaccine.”
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Focal
Point
GW’s Mary Ann
Stepp, Ph.D.,
probes the healing
potential of stem
cells to save the
sight of millions
By Steve Goldstein

I

f the eyes are the windows to the soul, then Mary Ann
Stepp, Ph.D., has the most soulful research job in medicine. Her focus is the eye, and specifically the cornea,
the clear outer layer, in studying the cellular mechanisms related to wound healing. Mysteries of sight are
revealed, and the potential for healing corneal damage finally
realized. Windows indeed!
And thanks to a dearth of doctoral programs, Stepp, who
was an aspiring nutritionist, changed direction to become
one of the leading researchers in her field.
As a member of the GW Stem and Progenitor Cell
Research Group, Stepp has been working with adult stem
cells found in the cornea to probe their potential for healing
damage from splashed chemicals, thermal burns, and other
injuries. Corneal erosions can develop after ocular trauma,
causing chronic inflammation and interfering with the
quality of life for millions of Americans. Corneal surface
injuries are painful and expose the eye to infectious microorganisms that can impair vision.
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A professor of anatomy and regenerative biology and
of ophthalmology at GW, Stepp received her first R01
grant for corneal research from the National Institutes of
Health in 1990 and has been continuously funded by NIH
since then — a winning streak of dynastic proportions.
Her secret? “Write a good proposal, and if your interests
match theirs, you’ll be successful,” she explains. But then
the slight, self-effacing scientist accumulates honors at a
daunting pace, including a 2010 Gold Fellow award from
the Association for Research in Vision and Ophthalmology
(ARVO). Stepp is also a tireless advocate for female Ph.D.s
at GW and for her lab partners.
Stepp examines the roles played by cell matrix adhesion
molecules, called “integrins,” during corneal and skin wound
healing, and in maintaining the stem cell population that
gives rise to the cells that make up the corneal surface. She
wants to understand how the cells that form the epithelial
niche of the cornea are maintained and what happens to
those cells and their niche when the tissue they serve is

injured. “To be able to prevent stem cell loss and recurrent
corneal erosions,” she says, “we need to understand how
they happen.”
Corneal abrasions are the most common reason a person
seeks out an ophthalmologist and are a regular cause of visits
to the ER, usually triggered by an errant fingernail. Infants
waving little hands often cause injury to their parents. Soldiers
experience eye trauma from shrapnel or debris. “Usually the
eye responds normally and there are no complications,” says
Stepp. “But I’m exploring how wound healing occurs so we can
help those who do have complications.” Such complications
may include lasting pain, watering of the eyes, the sensation
that something is in the eye, or scratchiness.
“When you sleep at night, your cornea swells because it’s
generating carbon dioxide, which builds up,” she explains.
“So your first blink of the morning is like a shirt that’s too
tight — the outer layer of cells can come off. You get focal
erosions that have to heal and can be painful. Every time that
happens, you weaken the adhesions of the epithelial to the
basement membrane. It’s like a spiral.”
Dimitri Azar, M.D., M.B.A., dean of the University of
Illinois College of Medicine and a cornea expert, calls Stepp
“one of the most highly talented researchers in the field of
corneal wound healing. Her studies on the role of epithelial
cells during a corneal wound, either in a situation of recurrent erosion syndrome or during wound healing, have had a
significant impact on our understanding of the mechanisms
of wound healing and our therapeutic interventions.”
Stepp’s upbringing shaped the course of her life. Her
father had a long career working for the Public Health
Service and her mother taught school. “I got an interest in
the allied health fields from my dad, and my mom gave me a
sense that you had to have a career and marry someone who’s
supportive of that career,” recalls Stepp.
Yet it was the stomach, not the eye, upon which she first
set her sights.
“One of the appropriate jobs for women when I was
growing up was a nutritionist or dietitian. There weren’t
very many programs, but I was able to get a scholarship to
go to Simmons College in Boston as a work-study student
and major in nutrition,” she says. But there were few Ph.D.
programs in nutrition, so Stepp was advised to pursue a
doctorate in biochemistry to advance in her chosen field.
The pivotal point in her career came during her doctoral
studies at Boston University, where she was working in a
lab studying the extracellular matrix, the part of animal
and human tissue that usually provides structural support
to the animal cells and is the defining feature of connective
tissue in animals. “That’s when I gave up on nutrition,” she
recalls. “I got interested in the extracellular matrix and the
biochemistry of that.”

That led to postdoctoral work at MIT in a lab directed
by Richard Hynes, Ph.D., well known for his work with
fibronectin, one of the extracellular matrix proteins. “It was
very exciting to study a new family of proteins called integrins. They integrate the intracellular part of the cell with the
extracellular matrix,” she explains. While attending a New
Hampshire conference related to her research, Stepp met
Ilene K. Gipson, Ph.D., of Boston’s Schepens Eye Research
Institute. Gipson recruited Stepp. “It seemed to me a niche
field was a good place to go because you could be identified as
an expert and have an impact,” Stepp says. “What attracted
me to the corneal studies was the simplicity and beauty of the
models that existed to study cell migration.”

Within eight months she had written a grant and
received funding through the National Eye Institute at
NIH. She was 32 years old. Her first office at Schepens was
a coat closet, but her salary doubled and she was able to
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pay her child care costs. In 1992, when her husband, Jerry
Bell, got an offer to work at the American Association for
the Advancement of Science in Washington, D.C., Stepp
joined the GW School of Medicine and Health Sciences as a
research assistant professor.
A new grant will allow her to continue research on treatment of perceived stem cell deficiencies in the cornea. “I’m
attempting to overthrow a paradigm,” she says with a quick
grin. Don’t bet on the paradigm.
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faculty news
to LaMantia, are formed in the correct numbers outside the
cortex, but are not able to move properly into the cortex where
they are needed to control cortical circuit activity.
“This gives us two pieces of the puzzle for this genetic
developmental disorder,” says LaMantia. “These two pieces
tell us that in very early development, those with 22q11.2
deletion syndrome do not make enough cells in one case,
and do not put the other cells in the right place. This occurs
not because of some degenerative change, but because the
mechanisms that make these cells and put them in the right
place during the first step of development have gone awry
due to mutation.”

Keeping the Cardiology
Community on the Beat

Genetic Lesion Blocks Neuron
Critical for Cortical Development
A little-known genetic irregularity has been identified as the
prime suspect in a developmental genetic defect leading to
disorders such as autism. Anthony-Samuel LaMantia, Ph.D.,
professor of pharmacology and physiology at GW’s School
of Medicine and Health Sciences (SMHS) and director of
the GW Institute for Neuroscience, along with postdoctoral
fellow Daniel Meechan, Ph.D., and Thomas Maynard, Ph.D.,
associate research professor of pharmacology and physiology
at SMHS, authored the study, titled “Cxcr4 Regulation of
Interneuron Migration Is Disrupted in 22q11.2 Deletion
Syndrome,” in the journal Proceedings of the National
Academy of Sciences (PNAS).
For nearly a decade, LaMantia and his colleagues have
been investigating how illnesses such as autism, attention
deficit hyperactivity disorder (ADHD), and schizophrenia
arise during early brain development. This latest research
focuses specifically on the effects on cortical circuit development of having lower levels of the gene 22q11.2.
According to LaMantia and his team, research shows for
the first time that genetic lesions known to be associated with
autism and other behavioral diseases disrupt the mechanisms
that ensure normal development of a key type of cortical
neuron: the interneuron. Previous investigations found that
among people who have these diseases, too little of another
type of cortical neuron, the projection neuron, is generated
during cortical circuit development. Interneurons, according
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Cynthia Tracy, M.D., professor of medicine at GW’s School
of Medicine and Health Sciences, and associate director of
the GW Medical Faculty Associates’ Division of Cardiology,
was recognized by the American College of Cardiology
Foundation (ACCF) and the American Heart Association
(AHA) for her efforts as writing group chair for the team
that updated the ACCF/AHA clinical practice guidelines.
The new guidelines will provide evidence-based guidance to physicians and other health care providers practicing
cardiovascular medicine. The standards will also help provide
a foundation for other applications, such as performance
measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
Tracy was chosen for this initiative because of her expertise and leadership at the national level and her service to the
cardiology community at large.

Health Sciences Faculty Honored
for Teaching Excellence

Speaking Out in Support of
Nutritional Standards for
Pregnant Women
Pregnant women in the United States face possible serious
side effects for both themselves and their unborn children
due to low levels of iodine in their diets. In an article from
the December 2012 edition of the Journal of the American
Medical Association, Alex Stagnaro-Green, M.D., MHPE,
professor of medicine and professor of obstetrics and gynecology at GW’s School of Medicine and Health Sciences
(SMHS), along with co-author Elizabeth Pearce, M.D.,
M.Sc., associate professor of medicine at Boston University
School of Medicine (BUSM), supports guidelines issued by
the American Thyroid Association, Endocrine Society, and
Teratology Society calling for pregnant women to take daily
iodine supplements.
“Iodine levels in the United States have been decreasing,
which has the potential to negatively impact the mother
and unborn child,” says Stagnaro-Green. “It’s time for all
health care professionals to make sure that every pregnant
and breast-feeding woman gets supplemental iodine during
pregnancy and while she is breast-feeding.”
Iodine is not naturally made in the human body and
must be consumed through foods rich in the element or
through supplements. Iodine is required for the production
of thyroid hormone, and adequate thyroid hormone levels
are critical for normal fetal neurodevelopment. National and
international health organizations currently recommend that
pregnant women take at least 150 milligrams of potassium
iodide daily.
“There is concern that even mild iodine deficiency in
pregnant women could lead to children with lower IQs,”
says Pearce. Iodine deficiency remains the leading cause of
preventable mental retardation worldwide.

GW School of Medicine and Health Sciences faculty
members Jennifer Halvaksz, M.A., assistant clinical professor
of physical therapy and health care sciences, and Karen
Schlumpf, M.P.H., lecturer in clinical research and leadership, received the 2013 Bender Teaching Award for their
demonstrated excellence in teaching and high academic
standards for achievement.
Halvaksz and Schlumpf join the ranks of other SMHS
faculty members who have been awarded the Bender
Teaching Award, including Gaetano Lotrecchiano, Ph.D.,
assistant professor of clinical research and leadership; Ozgur
Ekmekci, Ed.D., M.B.A., assistant professor of clinical
research and leadership; and Ellen Costello, Ph.D., associate
professor of physical therapy and health care sciences. Each
award includes a $1,000 prize to be used by the winners for
developmental activities.

Research Team Identifies
Biomarkers for Acute Kidney Injury
Two biomarkers used in combination can improve risk assessment of acute kidney injury (AKI), according to new research
from an international multicenter study. AKI strikes up to 7
percent of hospitalized patients and is associated with significant morbidity and mortality.
The results, published in the journal Critical Care,
address one of the most costly and deadly conditions
affecting critically ill hospitalized patients. The findings
provide much-needed insight into the most compelling
biomarkers of AKI.
AKI is a complex and increasingly prevalent condition.
Although it occurs quickly (over the course of hours to days),
it commonly presents a challenge in risk assessment due to
the inadequate tools currently available to physicians. Failure
to recognize and manage AKI in the early stages can lead to
devastating outcomes for patients and increased costs to the
health care system.
Lakhmir Chawla, M.D., associate professor of anesthesiology and critical care medicine at GW’s School of Medicine
and Health Sciences, and John A. Kellum, M.D., professor of
critical care medicine at the University of Pittsburgh, were part
of a two-part study on AKI, along with Kianoush Kashani,
M.D., assistant professor of medicine at the Mayo Clinic.
Researchers evaluated nearly 340 biomarkers to define the
two best biomarkers with the highest correlation to risk of AKI.
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Chawla and Kellum led researchers from 35 medical centers in
validating the effectiveness of the two novel biomarkers in 740
critically ill patients and comparing their performance with
other biomarkers, including serum creatinine.
The research teams confirmed that insulin-like growth
factor–binding protein 7 (IGFBP7) and tissue inhibitor of
metalloproteinases-2 (TIMP-2), both inducers of G1 cell cycle
arrest, were key mechanisms implicated in AKI. “The results
are striking not only in terms of identifying new robust
markers that have improved performance characteristics
when directly compared with existing methods for assessing
risk of AKI, but also in terms of bolstering understanding of
the mechanism of this disease,” says Chawla.

GW Faculty Members Lead the
Way for Women in Medicine
GW School of Medicine and Health Sciences faculty
members Katherine Chretien, M.D., associate professor of
medicine; Carolyn Clancy, M.D., associate clinical professor
of medicine; and Laura Tosi, M.D., associate professor of
orthopedic surgery, were among five distinguished women
honored at the sixth annual American Medical Student
Association (AMSA) Women Leaders in Medicine Awards.
According to Lexi Light, chair of AMSA’s Gender and
Sexuality Action Committee, Chretien, Clancy, Tosi, and
their fellow awardees “have committed themselves to education, social justice, and civic engagement.”

SMHS Alumna
Named Chair of
Dermatology
Alison Ehrlich, M.D. ’96,
M.H.S., clinical professor
of dermatology and director
of dermatology clinical
research, has been named
the new chair of the
Department of Dermatology
at the GW School of
Medicine and Health Sciences (SMHS).
“The GW School of Medicine and Health Sciences is
proud to have Dr. Ehrlich as its new chair of dermatology,”
says Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, vice president
for health affairs and dean of SMHS. “Her years of clinical
experience, research, and leadership in the field of dermatology make her the right candidate to lead and expand this
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department. We are especially pleased to have one of our very
own SMHS alumnae in this position.”
Ehrlich is an expert in the field of allergic contact dermatitis and founder of the GW Medical Faculty Associates’
psoriasis clinic, which offers patients a wide variety of therapy
options, including phototherapy, laser, biologics, and clinical
trials. She has been listed among America’s Top Physicians by
the Consumers Research Council of America and has been
named a Washingtonian Magazine “Top Doctor.”

Study Explores
Methods to Better Pair Patients
with Treatments
A study led by Robert G.
Hawley, Ph.D., professor and
chair of the department of
anatomy and regenerative
biology at the GW School
of Medicine and Health Sciences (SMHS), may help predict
which patients with multiple myeloma will respond better
to certain treatments. The study, titled “Identification of an
ABCB1 (P-glycoprotein)-positive Carfilzomib-resistant
Myeloma Subpopulation by the Pluripotent Stem Cell
Fluorescent Dye CDy1,” was published in April 2013 in the
American Journal of Hematology, 88(4), 265-272.
Multiple myeloma, the second most common blood
cancer in the United States, is an incurable malignancy
involving the white blood cells that normally produce
antibodies. As the disease progresses, the cancerous cells
accumulate in the bone marrow, causing painful bone lesions
and preventing normal blood cell production.
“Our hope is that the fluorescent assay we have developed will help physicians monitor the newest treatment
option for multiple myeloma patients and determine how well
it is working,” says Hawley.
Hawley and his team of researchers reported a test that
could be used to detect the multiple myeloma cells that
survive chemotherapy and are responsible for disease relapse
(referred to as tumor-propagating cells).
The researchers tested the hypothesis that the tumorpropagating cells in multiple myeloma exhibit stem cell–like
properties that confer resistance to the chemotherapeutic
agents used to treat patients. The team’s long-term goal is to
characterize these so-called “cancer stem cells” in order to
develop new targeted therapies that will eradicate the cells
and cure the disease.

faculty news
The next phase of the project, which is supported by a
pilot research grant awarded in 2012 by the Dr. Cyrus and
Myrtle Katzen Cancer Research Center at GW, will be to
translate the laboratory findings to the clinic. This work,
which will be carried out in collaboration with Imad Tabbara,
M.D., professor of medicine at SMHS, will involve screening
multiple myeloma patients to determine whether the CDy1
assay can help guide treatment decisions or predict which
patients will respond better to carfilzomib.

Art and History in Urology
Harry C. Miller Jr., M.D., professor and chair emeritus of
the Department of Urology at GW’s School of Medicine
and Health Sciences (SMHS), recently received the William
P. Didusch Art and History Award from the American
Urological Association (AUA), for his outstanding contributions to the written and photographic history of urology. The
AUA awards program honors the contributions of physician researchers and educators to the field of medicine, the
specialty of urology, and the association. Miller was a key
member of the SMHS faculty for 23 years, beginning in 1973,
until his retirement in 1995.
In retirement he remains active in medical organizations, serving on the boards of directors of the American
Urological Association and the American Association of
Clinical Urologists.

“Video capsule endoscopy performed by emergency
physicians was very accurate and nearly universally tolerated by patients,” says lead author Andrew Meltzer, M.D.,
assistant professor of emergency medicine at GW’s School
of Medicine and Health Sciences. “This is an example of the
‘whiz-bang’ side of emergency medicine that has the potential to save the health care system a great deal of money by
preventing the hospital admissions that are typically required
for esophagoduodenoscopy, a procedure used to diagnose
acute bleeding.”
Meltzer and his team enrolled 25 patients with suspected
acute upper gastrointestinal hemorrhage in their pilot
study. Capsule endoscopy was well tolerated by nearly all (96
percent) of the patients and showed 88 percent sensitivity and
64 percent specificity for the detection of fresh blood. There
was 92 percent agreement between gastroenterologists and
emergency physicians on test results.
The current gold standard of care for patients with acute
upper gastrointestinal hemorrhage is emergency esophagoduodenoscopy, performed almost exclusively by gastroenterologists
on patients who are admitted to the hospital. In 2011, 236,000
patients received the procedure in the hospital; they had an
average hospital stay of four days, costing $23,549 per patient.
By comparison, the average Medicare fee for the video capsule
endoscopy is $750 per patient.

The Next Phase of the
Fantastic Voyage
In the 1960s, it was the stuff of science fiction: the prospect
of journeying inside a patient to locate the source of illness
and identify the most effective means of treatment. Then,
about a decade ago, physicians began making that voyage
through the body by means of tiny video cameras the size
and shape of an oversized pill swallowed by the patient.
Now, emergency departments are exploring the use of video
capsule endoscopy to detect potentially life-threatening
acute upper gastrointestinal bleeding, enabling patients with
gastrointestinal hemorrhages to be treated without needing
to be admitted to the hospital.
A new study, titled “Video Capsule Endoscopy in the
Emergency Department: A Prospective Study of Acute
Upper Gastrointestinal Hemorrhage,” published in Annals
of Emergency Medicine, is the first to examine the use of
capsule endoscopy by emergency physicians for suspected
acute upper gastrointestinal bleeding.
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A Resident’s Humanistic
Approach to Medicine
By Laura Otto

A

s a resident, it’s easy to get overwhelmed by the
countless hours worked, the number of patients
seen and treated, and the volume of information digested. Christopher Bayne, M.D., knows
all about trying to balance long hours and little
sleep as a second-year resident at the George Washington
University School of Medicine and Health Sciences (SMHS),
without losing sight of what’s important and rewarding
about his job.
Bayne grew up not far from Washington, D.C., in Lake
Ridge, Va. As a star athlete in high school, Bayne experienced
a sports injury that first drew his interests toward medicine. “I
suffered a pretty bad ankle fracture playing soccer. My doctor
told me he thought I might walk with a limp,” he recalls. Bayne
underwent two orthopedic surgeries, sidelining him for most
of his freshman year. Despite the painful procedures during
the ordeal, Bayne has fond memories of his surgeon. “In my
mind, my surgeon was a miracle worker. Not only was I able to
kick a soccer ball again, but I went on play lacrosse.”
Initially, Bayne had no plans to pursue urology. He
vividly recalls a grueling review session on genitourinary
anatomy during his first year at Eastern Virginia Medical
School (EVMS). “I remember saying to myself, ‘There is no
way I’m going to become a urologist or even an obstetrician/
gynecologist,’ because the anatomy was so confusing and the
problems were so complex,” he says.
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It wasn’t until Bayne met Joshua Logan, M.D., chief
resident at EVMS, who would later become his mentor,
that he decided urology was the right choice for him.
“The urology program at my medical school ran a clinic
for people who couldn’t afford health care. As part of my
internal medicine rotation, I spent one day working with
Dr. Logan treating homeless men and women with urology
problems,” he says. Everything changed for Bayne after
working one-on-one with Logan.
Impressed by the cutting-edge robotics work going on
in GW Hospital’s Urology Department, Bayne knew this
was where he needed to be. For him, there was something
different about residents training in an urban environment.
Bayne had seen a da Vinci robotic procedure at other
hospitals, where surgeons used the high-tech device to
remove the prostate, but never with the level of professionalism he had witnessed at GW Hospital. “At the time,
most medical schools using robotics were in the trial-anderror phase, but at GW it had obviously been perfected,”
he recalls.
Because a resident’s routine is so demanding, it’s easy to
lose sight of what’s really important and rewarding about the
job. “At the end of the day, everything you do impacts your
patient directly,” Bayne says. “You can choose to go about it
routinely or you can take a little extra time to get to know
your patient and inject some kind of humanistic personalized
care.” This is precisely why Bayne is currently leading the
Arnold P. Gold Foundation’s new resident Gold Humanism
Honor Society chapter at SMHS. The Gold Foundation
is a nonprofit organization designed to bring humanistic,
patient-centered care back at every level of health care. Bayne
hopes SMHS will serve as a model for other medical schools
to follow. Going forward, he plans to organize small events
that interject a little humanism into the life of the residents.
It could be something as simple as an essay contest with
a humanistic theme. “We want to encourage residents to
reflect on the elements of their job that they find rewarding,”
he explains.
“As a resident, you have demands coming from every
corner,” Bayne continues. “Nothing can ever be done fast
enough or efficiently enough, and it’s easy to get bogged
down by the long hours and a heavy patient load.” For him,
it’s about the small, personal things, taking five extra minutes
to get a patient some fresh sheets and a pillow, for example.
Even though it’s not typically a doctor’s job, it helps his
patient sleep better. “Taking a little extra time to get to
know your patient and incorporate some kind of humanistic
personalized care gives your patient not only great medical
care, but a great health experience,” says Bayne.

Student Profile

In the Race for Research
By Laura Otto

k

ristin Ceniccola feels at home standing before a
lab bench collecting and analyzing data for her
latest research project. After all, it’s what she
does best, and she has the award to prove it.
Ceniccola, a third-year Ph.D. student in the
Institute for Biomedical Sciences (IBS) and a research assistant in the Department of Pharmacology and Physiology at
the George Washington University School of Medicine and
Health Sciences (SMHS), earned top honors at GW’s 2012
Health and Medicine Research Day during her second year
of doctoral studies, for her poster “The Glucagon Receptor
Functions as a Tumor Suppressor That Is Lost in AdvancedStage Hepatocellular Carcinoma.” Research Day is an annual
event at which students, faculty members, and residents
present their medical research initiatives and compete for
awards in posters and oral presentations. For Ceniccola, being
named the oral presentation winner for IBS solidified the

notion that she was on the right track. “Receiving that honor
meant that people were interested in the research I was
conducting and that it was important enough to be presented
to the academic community,” she recalls.
Currently, Ceniccola works with Norman H. Lee,
Ph.D., professor of Pharmacology and Physiology at SMHS,
looking at a receptor in liver cancer that functions as a tumor
suppressor. Until now, the receptor has been studied only in
the context of metabolism because it plays a role in diabetes
and other diseases that are not linked to cancer. Knowing
that this receptor plays an important role in cancer development, Ceniccola is exploring how she can best utilize or
exploit it for potential treatments.
Lee’s lab was a perfect fit for Ceniccola because it offered
her the mix of cancer research and molecular biology that
she couldn’t find in other labs, and Lee has also taken on a
mentorship role for Ceniccola. “Dr. Lee is very involved in
all the aspects of my projects,” says Ceniccola. “His door is
always open if I have a question or need advice.”
Ceniccola earned her bachelor’s degree in chemistry
from Cornell University. Her first research job involved
protein analysis of hydrogel particles. However, this type of
research didn’t have the impact she was looking for, and it
didn’t offer the amount of real-time bench science she craved.
Ceniccola decided to transition to biochemistry. GW’s
School of Medicine and Health Sciences caught her attention
because the IBS Department offered a mix of studies: cancer,
physiology, biology, and pharmacology. “I knew GW would
give me experience in a variety of different areas in biological
sciences,” she says.
When she’s not in the lab, Ceniccola is pounding the
pavement training for marathons. An avid runner, she sees a
lot of similarities between pursuing a Ph.D. and training for
a marathon, and running offers the perfect respite after hours
in the lab. “I can take some time out of my day and go for a
run and clear my head and think about things that need to be
done in the lab or related to my projects,” she says.
Ceniccola completed the 2012 Marine Corps Marathon
in an impressive 3 hours and 42 minutes. For her, it is important to find the right training plan to fit her busy schedule so
that she can achieve optimal results both at the bench and on
the pavement. “I like the way she approaches her marathon
training, which has great parallels with how she conducts her
research,” says Lee.
Ceniccola says it’s important for medical students interested in pursuing research to keep their options open and be
willing to explore different avenues of study. “Don’t be married
to your hypothesis,” says Ceniccola. “Because you may end up
finding something even more interesting and promising.”
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Pulling a Prestigious Career from a
Country Doctor’s Bag
The well-worn paths of a country doctor lead Floyd D. Loop, M.D. ’62, from rural Indiana to the
center stage of cardiovascular surgery
By Steve Goldstein
His left hand in his father’s, his right clutching the black
doctor’s bag, young Floyd Loop made the rounds with his
dad on the rural farms of Lafayette, Ind. It seemed the
right kind of life to the boy, the country doctor’s life. “I
interacted with a lot of patients and I saw their appreciation
and the gratification my father received,” he recalled seven
decades later.
And he did become a doctor, but events conspired to pluck
him from the pastoral setting of spending his career as a rural
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family doc, and led him to become one of the world’s leading
heart surgeons and head of the renowned Cleveland Clinic.
As graduation ceremony speaker for the GW School
of Medicine and Health Sciences (SMHS) class of 2013,
Floyd D. Loop, M.D. ’62, will speak about the opportunities
ahead for medical graduates. After graduating from Purdue
University and GW Medical School in 1962, he received
postgraduate surgical training at GW. He served in the
United States Air Force at Andrews Air Force Base, and later

trained in cardiothoracic surgery at the Cleveland Clinic.
In 1971 Loop was appointed to the staff of the Cleveland
Clinic. He became chair of the Department of Thoracic
and Cardiovascular Surgery in 1975, a post he held until 1989
when he was named chief executive officer of the Cleveland
Clinic and chair, Board of Governors.
Floyd Loop has performed more than 12,000 open-heart
operations and is the author of 350 papers on all aspects of
cardiovascular surgery. During his 15-year tenure as chief
executive, he led a reorganization of the clinic and enhanced
its academics. Under his leadership, the clinic built new
specialty and research buildings on campus and designed a
new health delivery system by acquiring eight Cleveland-area
hospitals and constructing an additional 14 outpatient clinics.
The Cleveland Clinic Lerner College of Medicine, the first
new U.S. medical school in 25 years, opened in 2002.
His experience in Washington, D.C., shaped his career.
Unlike the modern digs of today, the medical school of
Loop’s days at GW was housed in a Civil War-era building
in the 1300 block of H St., N.W. “I liked to go to the old
bookstores and browse for hours,” he recalls. “You could walk
everywhere. My roommates and I lived in northern Virginia
and I had an old Vespa motor scooter we used to get to class.
I remember seeing Vice President Richard Nixon, who was
being driven to ‘work.’ He always waved to us. Washington
was a real sleepy town then.”
Following his second year, Loop started his rotation
through the various services and quickly took a liking to
surgery. This brought him into contact with Brian Blades,
M.D., the former Lewis B. Saltz Chair of Surgery. “The
surgeons on his staff were superb, and they were excellent
teachers,” says Loop. In return for a draft deferment to finish
his residency, Loop agreed to serve in the Air Force. Blades
arranged for Loop to serve at Andrews Air Force Base, where
he gained surgical experience. “I got a year’s credit on my
residency and returned to GW to complete my residency,”
Loop says.
After completing his third year of training, Loop sought
out Blades and related his intended plans. “He listened
patiently and then he said, ‘No, you’re going to the Cleveland
Clinic,’ ” Loop remembers. “His first resident, Don Effler,
M.D., ran the program there. Blades said things were changing
in cardiac surgery and Effler and his staff were in the forefront.
I took his advice and that was a defining moment.”
Loop gained an international reputation as a heart
surgeon. He assembled a group of skilled and experienced
thoracic and cardiovascular surgeons who helped enhance the
clinic’s reputation. Loop and his colleagues were responsible

for today’s widespread use of arterial conduits in coronary
artery surgery, innovations in valve repair, and pioneering
technical improvements for re-operations.
Under his leadership, the Cleveland Clinic rose to be
ranked consistently in the 10 top hospitals in the United
States. “He had a solid vision for growth for the clinic’s
health system,” current CEO Delos Cosgrove, M.D., told
Crain’s Cleveland Business. “He pushed the organization in
the right direction that was fundamental to achieving our
current status.”
Loop says he foresees further innovations in heart
surgery for less invasive surgery. Today he serves on public
and private corporate boards. In 2009, he published a book,
titled Leadership and Medicine. “I think physicians should lead
health care institutions,” he explains. “They can talk to fellow
doctors better than business people can, and they can always
learn business fundamentals.”

Under his leadership, the Cleveland Clinic
rose to be ranked consistently in the 10
top hospitals in the United States. Loop
was named one of 30 persons who made
the greatest contributions to Cleveland in
the past 30 years.
Orchids, gardening, and orchards form Loop’s horticultural passions. His constant companions are a pair of golden
doodles named Lewis and Clark. He also keeps in close
contact with his four daughters. He was married for 25 years
to cardiologist and former National Institutes of Health (NIH)
Director Bernadine Healy, M.D., who died in August 2011.
“We kept an apartment in Washington when she was at NIH
and the Red Cross, but she came home to Cleveland every
weekend,” he says. Healy was the first woman to lead NIH.
Loop says he once imagined himself as a civil engineer, but that career path was “always a distant second.”
His father’s experience was instructive — and seductive.
Nevertheless, the boy clutching his country doctor father’s
black bag, dreaming of a life of bucolic medicine — “delivering babies, fixing hernias, making house calls” — got a little
sidetracked. “Those were good days, and they gave me some
incentive,” Loop says. Doubtless, those residents of rural
Indiana who may rue the loss of a young practitioner, but will
admit Loop’s heart was always in his work.
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SMHS Alumnus
Richard Popiel
Awarded the
2013 Alumni
Outstanding
Service Award
Richard Popiel, CCAS B.A.
’75; SMHS M.D. ’81, G.M.E.
’83; and member of the GW
Alumni Association’s board of directors, representing the
School of Medicine and Health Sciences, was awarded the
2013 Alumni Outstanding Service Award on Apr. 18. Not
only does Popiel lend a balanced voice on important issues
pertaining to GW, but he is working to raise more than
$100,000 to endow a scholarship for the M.D. class of 1981.
Last fall, Popiel was invited by GW President Steven Knapp
to present on the topic of health care management and leadership at the president’s reception in New York on Oct. 23.
As a leading expert on health care management, Popiel
was recently named senior vice president, health care
services, and chief medical officer for all of the Regence
Group’s health insurance plans. In this role, Popiel leads
medical strategy and provides executive leadership on
addressing care initiatives and cost management.
Prior to joining the Regence Group, Popiel served as
president and chief operating officer of Horizon Healthcare
Innovations. Under his leadership, Horizon Healthcare
Innovations launched more than 30 pilot programs involving
80,000 members, such as medical home projects and
accountable care organization partnerships. These accomplishments, which improved health outcomes while curbing
costs, are cited as effective industry case studies.

He has held leadership positions for key organizations
throughout his career. Popiel served as vice president and
chief medical officer at Horizon Blue Cross Blue Shield
of New Jersey, was a member of the board of directors of
Horizon Healthcare of New Jersey, and was the chair of the
National Council of Physician and Pharmacist Executives,
among other notable roles.
In addition to his degrees earned at GW, he holds an
M.B.A. from Northwestern University. Popiel lives with his
wife in Portland, Ore. Their two sons are current undergraduates at GW.

Sogani Ascends to American
Urological Association Presidency
Pramod C. Sogani, M.D., G.M.E. ’71, FACS, FRCS, a
urological oncologist and attending surgeon at Memorial
Sloan-Kettering Cancer Center (MSKCC), assumed the presidency of the American Urological Association (AUA). The
110-year-old association is the premier professional association for the advancement of urologic patient care.
Sogani served as president-elect from May 2012 until
the AUA annual meeting in San Diego, May 8, 2013.
Previously he served as treasurer, president, and representative to the board of directors for the New York section
of the AUA. He was the recipient of the Sasruta Award of
Excellence in Urology of the Indian American Urological
Association, the John K. Lattimer Award of Excellence
in Urology of the Kidney Foundation of America, the
Distinguished Service Award of MSKCC, the Award of
Distinction of Weill Cornell Medical College, and the
Russell W. Lavengood Distinguished Service Award of the
New York section of the AUA.

1960s

1970s

Leonard Wartofsky, M.D. ’64, B.S. ’59, received the
2012 Robert H. Williams Distinguished Leadership Award of
the Endocrine Society. In 2011, Wartofsky received the GW
Distinguished Alumnus Award. He is also editor-in-chief of
The Journal of Clinical Endocrinology & Metabolism.

Brian Schulman, M.D. ’71, B.A. ’68, was named to

Marilyn Renfield, M.D. ’65, G.M.E. ’66, GW assistant
clinical professor of psychiatry and behavioral science,
received the Elaine W. Cotlove, M.D. Award for Excellence
in Psychiatric Education.
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Washingtonian Magazine’s Top Doctors 2012 edition for psychiatry.

Robert Bransfield, M.D. ’72, recently published the

following journal articles: “Can Infections and Immune
Reactions to Them Cause Violent Behavior?” in the
Proceedings of the 11th Psychoimmunology Expert Meeting,
Gunzburg, Germany, March 10, 2012, Neurology, Psychiatry,
and Brain Research, 18(3); “Relationship of Inflammation and
Autoimmunity to Psychiatric Sequelae in Lyme Disease,”

Psychiatric Annals, 42(9), 337-341; “The Psychoimmunology
of Lyme/Tick-Borne Diseases and its Association with
Neuropsychiatric Symptoms,” The Open Neurology Journal,
6 (Suppl 1-M3), 88-93; and “Long Term Antibiotic Therapy
May Be an Effective Treatment for Children Co-Morbid with
Lyme Disease and an Autism Spectrum Disorder,” with Kuhn
et al., Medical Hypotheses, 78(5), 606-615.
George Korengold, M.D. ’72, was named to
Washingtonian magazine’s Top Doctors 2012 edition
for pediatrics. Korengold was also named the 2012
Montgomery-Prince George’s County Pediatric Society’s
Pediatrician of the Year.
David Kestenbaum, M.D. ’74, a gastroenterologist with
Kaiser Permanente in Fontana, Calif., will retire after nearly
40 years of practice. He served as chief of the division of
gastroenterology for 22 years at Kaiser.
Alan Sager, G.M.E. ’76, GW associate clinical professor

of Psychiatry, was named to Washingtonian magazine’s Top
Doctors 2012 edition for psychiatry.
Donald W. Allen, M.D. ’77, adjunct associate professor of

family and preventive medicine, University of Utah School
of Medicine, received the 2012 Outstanding Teacher Award,
University of Utah Physician Assistant program. In addition to holding his faculty position, Allen serves as medical
director for both Park City Medical Center, and Utah and
Idaho — Encompass Home Care and Hospice.

Dale H. Isaacson, M.D. ’77, G.M.E. ’81, was named

to Washingtonian magazine’s Top Doctors 2012 edition
for dermatology.

Barbara Snyder, M.D. ’79, associate professor of medi-

cine and chief of the Division on Adolescent Medicine at
Robert Wood Johnson School of Medicine, was named a
“Best Doctor” by New York Magazine for 2012. It marks the
fifth consecutive year Snyder has made the list.

Save the date
GW school of medicine

2013 �lumni �eekend

September 27-29, 2013
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Kassan Masters
Rheumatology
Stuart Kassan, M.D. ’72,
member of the George
Washington University
board of trustees representing the School of
Medicine and Health
Sciences, was awarded
the title of master by
the American College of
Rheumatology (ACR) during the November 2012 ACR
Annual Meeting, in Washington, D.C.
The distinction is conferred by the board of directors
of ACR, for those members who have made outstanding
contributions to the field of rheumatology through scholarly achievement and/or service to their patients, students,
and profession.

1980s
Kevin Michael Gil, M.D. ’80, was named to

Washingtonian magazine’s Top Doctors 2012 edition for
family medicine/geriatrics.

Jane Bening, M.D. ’81, was the featured speaker at the
Vibrantly You Women’s Wellbeing Symposium, La Costa
Hotel and Spa, Carlsbad, Calif., in January 2013.

1990s
Raj Goyal, M.D. ’93, B.S. ’89, recently served as the

primary investigator in pivotal clinical trials of iStent.

Karen Alton, M.D. ’95, was voted a Southeast Michigan Top

Doc in Adolescent Health for 2012 by www.hourdetroit.com.

Dominique Howard, M.D. ’97, G.M.E. ’00, GW assistant

clinical professor of medicine, was named to Washingtonian
magazine’s Top Doctors 2012 edition for gastroenterology.
Howard was also elected to serve as president of the William
Earl Clark Society.

Kassan serves as chief medical officer with Aspire
Behavioral Health in Denver and has served as a clinical
professor of Medicine at the University of Colorado Health
Sciences Center since 1994. He also currently practices at the
Colorado Arthritis Associates in Lakewood, Colo.

Health Care
Humorist
John F. Hunt, M.D. ’92, associate
professor at the University of
Virginia, and co-founder of the
Trusted Angels Foundation — a
nonprofit organization that works for
children in Liberia, West Africa —
recently published Assume the Physician,
a satirical novel about the current
health care system and the causes of
medical hyperinflation.

Ian W. Marks, M.S. ’00, wrote the chapter “Spine” for

the textbook Orthopaedics for Physician Assistants (Elsevier),
published April 2013. Lt. Marks, U.S. Coast Guard, recently
returned from deployment to CENTCOM as a medical
officer supporting Operation Enduring Freedom and
Operation New Dawn.
Dave Bright, M.D. ’01, is the teaching attending physician
at Mercy Medical Center, and assistant professor of medicine,
University of Maryland School of Medicine.
Thomas W. Sorber, M.S. ’01, was named chair of the

Physician Assistant Executive Committee at University of
Rochester Medical Center.

Eric Wollins, M.D. ’02, was named a 2013 “Top Doctor”
in gastroenterology by Northern Virginia Magazine, and was
named among the 2013 “Super Doctor Rising Stars” by the
Washington Post Magazine.
Jeffrey Anderson, M.S. ’07, board-certified pharmaco-

2000s

therapy specialist, was named system director of pharmacy
services for Yavapai Regional Medical Center — Prescott and
Prescott Valley, Ariz.

Theresa Jerussi, M.S. ’00, was recently appointed as an

Karen Buikema, M.S. ’08, received the 2013 Marquette

adjunct faculty member of GW’s Physician Assistant program.
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Professional Achievement. In 2010, Buikema received the
United States Air Force Medical Service Clinical Laboratory
Manager of the Year award.

for 2012–13; serves on the AAPM+R Board of Governors for
2012–13; and was accepted to the pre-application phase of the
Rehabilitation Medical Scientist Training Program.

Jaclyn Albin, M.D. ’09, will serve as pediatric chief resident

Tommy Lee, M.S. ’11, published the article “Spray-applied

at Texas Children’s Hospital for the 2013–14 academic year.

Thomas Joseph Maruna, B.S. ’09, who passed the
United States Public Health Service boards and was
commissioned in April 2013, has been promoted to hospital
administration, focusing on quality assurance.

Shilpa Agarwal, M.D. ’12, B.A. ’08, completed her
residency in family medicine, and is board certified in both
family medicine and integrative and holistic medicine.

Mindy Ditch, M.S. ’10, was recently promoted to clinical

project manager at St. Jude Medical, where she manages a
pediatric heart valve clinical trial.
Andrew H. Gordon, M.D. ’10, was elected president

Cell Therapy with Human Allogeneic Fibroblasts and
Keratinocytes for the Treatment of Chronic Venous Leg
Ulcers: a Phase 2, Multicentre, Double-blind, Randomised,
Placebo-controlled Trial,” in The Lancet, 2012; 380, 977-985.

Rehan M. Hussain, M.D. ’12, B.A. ’08, ophthalmic

of the Resident Physician Council Board of the American
Academy of Physical Medicine and Rehabilitation (AAPM+R)

pathology fellow for 2012–13 at Bascom Palmer Eye Institute,
recently matched into an ophthalmology residency program
at Indiana University (beginning July 2014).

New job? Publication? Change of address? Share your news. Please send your Class Notes to: Email, smhsalumni@gwu.edu,
call (202) 994-7511, or log on to smhs.gwu.edu/alumni/update-form

Do You Own Property?
o Do you have property that is a burden to manage?
o Do you own property you don’t use anymore?
o If you sell a property, will you owe significant taxes?
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If so, GW can help. By donating real estate to GW, you can achieve peace
of mind, create a lasting legacy in support of the university and receive
financial benefits for yourself or someone else.
What’s in it for you?
Depending on the nature of your gift and your objectives, you could:
• Avoid capital gains taxes on appreciated property
• Eliminate the burden of maintaining and paying for the property
• Provide yourself with an annual income
• Continue to use the property for the remainder of your life
• Reduce your estate and income taxes
• Help the program of your choice
GW accepts many types of property including residential and
commercial property, and undeveloped land.

For more information, please contact
Chase Magnuson, Director of Planned
Giving for Real Estate at 202-994-4979
or chasem@gwu.edu.

The George Washington University
Office of Planned Giving – Real Estate
2100 M Street, NW, Suite 310
Washington, DC 20037

DAR1762
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In Memoriam

Philip J. Balestrieri, M.D. ’87
Philip T. Band, M.D. ’45
John G. Batsakis, M.D. ’55

Frank Miller, M.D. ’48, B.S. ’43,
professor emeritus of pathology at GW’s
School of Medicine and Health Sciences
(SMHS), passed away April 24, 2013.
“As a professor, mentor, and friend,
Dr. Miller was one of the most beloved
faculty members in the history of GW’s
School of Medicine and Health Sciences,
and he will be missed by so many within
our community,” said Jeffrey S. Akman,
M.D. ’81, G.M.E. ’85, vice president for
health affairs and dean of SMHS.
Miller’s dedication and influence as a teacher, shaping the future
careers of generations of medical students from 1944 until his retirement
in 1985, earned him GW’s Distinguished Teacher Award in 1998. Because
of his ability to connect with students and mentor residents and fellows, he
was GW’s first recipient of the “Golden Apple” award, presented to him for
excellence in teaching the basic sciences. By the time Miller retired, he had
been awarded seven such prizes — an unprecedented total at the time.
Miller was embedded in the cultural fabric of GW. His legacy will
live on through the Dr. Frank N. Miller Endowed Professorship, which
supports a distinguished teaching professorship in SMHS, and the Dr.
Frank Miller Award, given annually to a pathology resident or fellow in
recognition of excellence in teaching.
Miller is survived by his wife, Caroline Sykes Miller; son, Donald
Miller; and daughter, Catherine Sluder, manager of the Bloedorn
Technology Center in GW’s Himmelfarb Health Sciences Library.

Zale P. Bernstein, M.D. ’80
Herbert E. Block, M.D. ’40
Anita M. Bosch, PA ’00
Nancy Bruckner, M.D. ’76
Richard G. Call, M.D. ’60
Beth Ann Collins, M.D. ’70
Richard M. Cooper, M.D. ’66
Jere Jack Daum, M.D. ’57
Harold A. Davis, M.D. ’45
Robert M. Deliman, M.D. ’53
Frank Denaro, M.D. ’63
David A. Dews, CERT ’08
David George Dixon, M.D. ’57
Paul A. Dorn Jr., M.D. ’70
Robert L. Greenlee, M.D. ’49
Marie A. Hanache, M.D. ’57
Forest K. Harris, M.D. ’53
Roberta Katlan Helfgott, M.D. ’72
James E. Jackson, M.D. ’59
Allen L. Kauffman, M.D. ’62
Gideon Musyimi Kioko, M.D. ’73
David Alan Lincoln, M.S. ’04
J. David Linehan, G.M.E. ’79
Lawrence C. Marcella, M.D. ’55
Debra S. McMahan, M.S. ’01
Herbert A. Miller, M.D. ’61
Albert J. Modlin, M.D. ’54
Richard H. Mott Jr., M.D. ’50
John P. Naughton, M.D. ’59

Gaetano Molinari, M.D., former chair of neurology at GW’s

School of Medicine and Health Sciences (SMHS), died Dec. 14, 2012, after
a long illness. He was 76 years old. In the early 1970s, Molinari was the
head of stroke research at the National Institutes of Health; he joined the
SMHS faculty in 1976. Molinari retired in 1994, but he continued lecturing
as a clinical expert on stroke for many years afterward. He was a member
of Alpha Omega Alpha, a former captain in the U.S. Air Force, and a
Vietnam veteran.

Geraldine W. Paul, M.D. ’64
Donald K. Pine, M.D. ’52
Melvin A. Porter, M.D. ’49
John E. Prichard, M.D. ’48
James Mark Rogers, A.S. ’81
Ashley Ann Sobczak, CERT ’05
C. Herbert Spencer, M.D. ’50
Ryan Baccus Squires, CERT ’05, A.S. ’07
Donald Stubbs, M.D. ’32
Kenneth C. Sze, M.D. ’43
William F. Thompson, M.D. ’67
H. Robert Unger, M.D. ’52
Warren E.C. Wacker, M.D. ’51
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In Development

Investing in the Future of Medicine

T

he George Washington University School of Medicine and
Health Sciences (SMHS) is making great strides in its mission
of education, patient care, and research. In these pages, you’ll
find many stories about SMHS programs of excellence that are
elevating GW’s reputation and changing the face of medicine.
Achieving our goals requires major financial investments,
and we invite our community to help us. Philanthropy has never been more
important. In addition to outright gifts, there are a number of creative and
sophisticated methods of giving that can result in substantial tax and financial advantages to donors. For example, GW has a very active real estate
donation program. SMHS accepts a broad range of real estate gifts, subject to
approval by the GW gift acceptance committee. Some examples are below.
•S
 econd homes, including beach condos, mountain cabins, or ski chalets
that are no longer in use by family members, can constitute excellent
donations.
•M
 edical office suites or complexes that house a practice that is being sold
can be donated. By contributing the real estate and selling the practice,
the donor can create a meaningful legacy at the school.
•R
 ental properties that have management difficulties or low rates of
return might effectively be used to fund a lifetime income stream for the
donor, which can be guaranteed by GW in some cases.
Additionally, donors who are age 70 1/2 and older may now contribute
up to $100,000 tax-free directly from their IRA; however, this opportunity
expires on Dec. 31, 2013.
GW’s development professionals are knowledgeable about these topics.
Please remember SMHS in your philanthropy plans and contact the Office of
Development and Alumni Relations, with no obligation, if you desire further
insight and information on these and other methods of giving.
Thank you,

Dennis Narango, M.A., C.F.R.E.
Associate Dean, SMHS and Associate Vice President for GW Medicine
Development and Alumni Relations
email: dnarango@gwu.edu
phone: (202) 994-7511

If you are interested in supporting any of the initiatives featured in this magazine, visit www.gwu.edu/give2gw
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Jumping to Solutions
Researcher Sally Moody uses frog embryos to clear the knowledge
gap in neural regeneration . Read more on page 14

